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Chemical insights in bioinks for 3D printing 
Laurine Valot,a,b Jean Martinez,a Ahmad Mehdi,*b and Gilles Subra*a 
3D printing has triggered the acceleration of numerous research areas in health sciences, which traditionally 
used cells as starting materials, in particular tissue engineering, regenerative medicine but also in the design 
of more relevant bioassays for drug discovery and development. While cells can be successfully printed in 2D 
layers without the help of any supporting biomaterial, the obtainment of more complex 3D architectures 
requires a specific bioink, i.e. a material in which the cells are embedded during and after the printing process 
helping to support them while they are arranged in superimposed layers. The bioink plays a critical role in 
bioprinting: first, it must be adapted to the 3D printing technology, then, it must fulfil the physicochemical and 
mechanical characteristics of the target construct (e.g. stiffness, elasticity, robustness, transparency); finally it 
should guarantee cell viability and eventually induce a desired behaviour. This review focuses on the nature of 
the bioink components from natural or synthetic origin, and highlights the chemistry required for the 
establishment of the 3D network in conditions compatible with the selected 3D printing technique and cell 
survival. 
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1. Introduction 
Supported by recent advances in 3D printing 
technology, researchers have explored new 
avenues for cell-based therapies and tissue 
engineering using cell encapsulated biomaterials. 
From a technical point of view, bioprinting is now 
feasible with a wide range of 3D printers, which are 
more and more affordable, reliable and easy-to-
use, ranging from basic to sophisticated setups 
(more than one extruder, better resolution in 
deposition and thickness, etc.). Numerous inks are 
now readily available, meeting all the physical and 
chemical requirements for 3D printing on a 
particular device (e.g. extrusion, ink-jet, laser-based 
printer, etc.). Perhaps the simplest way to prepare 
cell-containing materials is first to print the scaffold, 
and seeding its surface with cells afterwards. 
Nevertheless, it is a much more challenging goal to 
design a bioink - i.e. an ink already encapsulating 
cells before printing. There are additional 
constraints for encapsulating cells from the 
beginning, guaranteeing their survival during the 
bioprinting process and guiding their behaviour 
once embedded in the final printed scaffold. On the 
other hand, 3D-bioprinting allows a homogeneous 
distribution of cells inside the construct and may 
yield more complex structures (e.g. for co-culture), 
compared to basic seeding on the surface of a 
printed scaffold. This major advantage is obtained 
at the cost of more restrictive 3D-printing 
procedures (no heating, no organic solvent, etc.) 
and the nature of the bioink, which can only be 
hydrogel. 
Although there are many papers on these topics, 
neither 3D printing of cells alone suspended in 
culture medium or DPBS buffer (without any 
hydrogel support), nor works dealing with 3D 
printed objects seeded with cells, will be covered in 
this review. In the last 5 years, the number of 
publications on 3D printing has skyrocketed (Fig. 1), 
but only a small amount of them (less than 6%) 
really concerns bioprinting and only a minority of 
these articles describes a new bioink composition 
as most of the papers are focussed on new 
applications using well-known hydrogels (e.g. 
alginate, gelatin). Nevertheless, to mimic the 
biological complexity and the heterogeneity of 
natural tissues, it is important to have access to a 
wide range of different bioinks whose nature, 
physical and chemical properties can be chosen in 
accordance with the 3D printing method. This 
review focuses on bioink chemistry, which has 
already enabled the biofabrication of vessels,1–3 
tissues and skin,4–9 cartilage10–12 and bone.13–16 
Besides artificial organs,17–21 the preparation of 
relevant 3D models22–24 recapitulating the 
microenvironment of natural tissues has also been 
successfully performed by 3D bioprinting, in 
particular for screening of anticancer drugs and 
comprehension of tumour invasion mechanisms.25–
28 3D biofabrication can also be merged with either 
improved drug delivery29,30 by encapsulation of 
drugs inside the scaffold, or cell therapy.31 
 
  
 
 
Fig. 1 Evolution of the number of publications by year on 3D printing (red) and on 3D-bioprinting (blue). 
Number of publications according to Web of Science from 1983 to 21st September 2018. 
 
The nature of bioink is intimately associated with 
the different biocompatible 3D-printing 
technologies (Fig. 2), which are the topic of the 
following section. The chemical nature of bioink 
components [i.e. the (bio)polymers and building 
blocks used to establish the hydrogel network], and 
the chemical process leading to the cross-linking of 
the hydrogel will be discussed extensively in the 
third and fourth sections, respectively. Finally, we 
will try to ascertain what could next be contributed 
to the field of bioprinting by the creativity of 
organic, bioorganic or polymer chemists. 
2. Biocompatible 3D-printing techniques: 
influence on bioink design 
An obvious prerequisite to printing cells is to use a 
printer technique, which preserves the cell integrity 
during the 3D printing process. Fortunately, most of 
them are compatible with cell printing and cause only 
little trauma to the cells. Each technique is 
compatible with only some gelation processes (see 
2.2-2.7 and chapter 4) and also requires inks that 
show specific mechanical and physical properties. 
Usually, it is the bioink that is adapted to the printer 
and not the other way round, mainly because of the 
cost of the apparatus (from $100 for the cheaper 
fused deposition modelling printers, $5000 for the 
simplest extrusion printer to one million dollars for a 
laser-based printer), even if a particularly attractive 
bioink can be assayed on different printers.32 Big 
improvements have been made in 3D-printing 
technologies, offering new capabilities (such as 
multiple print-heads with different 3D printing 
technologies on the same printer) and better 
performance, for a lower cost by an ever growing 
number of manufacturers.32 As obvious as it may 
seem it must be pointed out that 3D-bioprinting of 
big objects will always be limited by (i) the 
dimensions of the printer, (ii) the amount of bioink 
needed, and (iii) the size of the bioink reservoir. For 
further description of commercially available bio- 
printers, the reader can refer to a very complete 
review by Ozbolat et al.32 
 
 
Fig. 2 Connexions between bioink characteristics, 
cells and printer. 
 
2.1. Biological prerequisites for bioprinting 
To print cells, a printing process must respect some 
rules linked to the gelation reaction and the 
ejection/shaping of the material. Obviously, 
temperature, pH, irradiation (UV, laser jetting, etc.) 
and pressure must be adapted to reduce cell 
mortality, considering that cell lines have different 
resistance to these parameters. Interestingly, 
compared to direct printing of cells alone, the 
embedding material (i.e. the bioink) may protect the 
cells for a limited time from exposure to lethal 
conditions (pressure, irradiation, etc.). However it is 
not advised to: 
  Print above 50 °C or below 5 °C, otherwise it will 
induce cell death or growth retardation; 
 Work at pH below 6.5 or above 7.8, because it will 
induce poor cell viability;33 
 Use organic solvents or cytotoxic compounds 
(e.g. toxic catalysts, linkers, etc.). This means that 
only aqueous solutions can be bioprinted; 
 Extrude with a high pressure (limits depend on 
cells and embedding material). As an example, 
when rat endothelial cells (RAMEC) suspended 
into an alginate hydrogel were extruded at 40 PSI, 
because of the effect of pressure, the survival 
rate fall to 60%.34 
Moreover, conservation of cells in the ink prior to the 
printing process implies that the cell-embedded 
material follows basic sterility rules to avoid any 
bacteria or fungi contaminations. The bioink material 
needs to be prepared in sterile conditions or 
sterilised. It can be done by:  
 Filtration if it is liquid enough, with a 0.22 µm 
filter,  
 UV irradiation for a transparent solution or 
hydrogel, but only if it cannot undergo 
unwanted UV-crosslinking reactions, 
 Autoclaving, only for compounds and 
solutions that are stable at high temperature, 
high pressure and humidity (i.e. up to 130°C 
with a humidity saturated atmosphere).  
Of course once the cells are added to the bioink 
solution, the subsequent steps of the preparation of 
bioink (e.g. filling the reservoir, preliminary cross-
linking), the printing process, and after-printing 
treatments must be performed under a sterile hood. 
It is worth noting that most 3D printers are small 
enough to fit inside a sterile hood thus easily 
complying with sterility requirements. The design of 
some other bioprinters include a sterile hood (e.g. 
Biofactory and 3DDiscovery from Regen Hu, Bio X and 
Inkredible + from Cellink, and 3Dn-300-TE from 
nScrypt). 
 
Fig. 3  Bioprinting-compatible techniques: (A) Extrusion and co-axial extrusion, (B) Fused deposition 
modelling, (C) Inkjet bioprinting, (D) Laser assisted bioprinting, and (E) Stereolithography. 
2.2. Extrusion 
Extrusion is the most commonly used technology of 
bioprinting. The bioink is pushed through a nozzle/tip 
to deliver a ribbon that will give the desired shape of 
a layer by x/y movement of the print head (Fig. 3A). 
Once the first layer printed, the nozzle moves 
upwards (or the receiving plate moves downwards) 
to print the second layer, and so on. Depending on 
the printer model, extrusion is induced by either an 
endless screw, an air compressor or a mechanical 
piston. Each type of device gives access to a particular 
range of pressure (lower for endless screw and higher 
for air compressor). One of the advantages of this 
technique is the ability to easily add extra injectors to 
the printer, to deliver several different bioinks in 
alternation or delivering the same type of ink, 
encapsulating (or not) different types of cells. This is 
particularly useful for fabricating complex multilayer 
and multi-area constructions. This technology is also 
amenable to co-axial extrusion (Fig. 3A) yielding a 
sheath filled with another bioink or a different 
ink/solution. It is particularly useful for printing, along 
with the bioink, either a ‘sacrificial ink’, which will be 
removed after printing, or an ink which does not 
contain cells but a gelator (e.g. a catalyst or a cross-
linker reagent), which migrates to another bioink to 
induce gelation. This technique is of huge interest for 
vessel fabrication, and is explored in sections 4.1.2. 
and 4.2.2. of this review.  
In contrast to other printer technologies, a bioink 
suitable for extrusion-based printing should have a 
high viscosity (from 30 to 6*107 mPa/s, depending of 
the extruder of the printer),22 a good shape retention 
once printed to avoid flooding, and a fast gelation. To 
increase viscosity until a ‘printability’ level is reached 
or to trigger the gelation of the bioink, extrusion can 
be coupled with heating or UV irradiation. 
Heating/cooling can be performed on the whole 
extruder or just limited to the nozzle, or even on the 
receiving plate using the Peltier effect, as far the 
temperature is tolerated by cells. When required, 
UV-irradiation is performed either at the exit of the 
extruder to photo-polymerize the bioink, or directly 
on the printed scaffold. In the latter case, the 
structure should be tough enough to keep its shape 
until cross-linking. The flexibility of this technique 
means that a wide range of bioink types (i.e. chemical 
hydrogels and physical hydrogels) can be 
accommodated on extrusion-based printers. 
Additionally, this methodology is particularly useful 
for rapid prototyping and the fabrication of relatively 
large objects (from vessels to organ sizes). 
Interestingly, there is no cell concentration 
limitation, in comparison with inkjet, which allows 
only a low cell density, and laser-based bioprinting 
(moderate density, see Table 1). On the other hand, 
the high speed of material delivery is detrimental to 
the resolution (> 100µm).35 Depending on the size of 
the cells, laboratories generally work with nozzle 
diameters higher than 32 Ga (0.1mm).36,37 
 
2.3. Fused deposition modelling (FDM) 
Fused deposition modelling (FDM) technology is 
quite similar to extrusion printing, but additional 
heating changes the physical state of the material on 
its way through the printer head. It is based on the 
fusion of a material, usually either thread-shaped or 
formulated as beads in the reservoir. The deposition 
of the melted material is then performed by a print 
head (Fig. 3B). This technology is widely used for 
thermo-responsive polymers and plastics. However 
its application in bioprinting remains highly limited, 
because of the high temperatures required for fusing 
the material and its plastic nature (no aqueous 
medium for cells), which is usually incompatible with 
cells. Only a few materials with either a low melting 
point [e.g. 60 °C for polycaprolactone and 31 °C for 
poly(lactide-co-caprolactone)] or a low glass 
transition temperature (from a rubbery and 
amorphous state to a glassy/crystalline state, e.g. 60 
°C for polylactic acid, 16 °C for poly(lactide-co-
caprolactone) and 40-60 °C for poly(lactic-co-glycolic 
acid)) can be used. For these reasons, this technology 
is often used to print non-cellularized scaffolds that 
will support a bioink, which is not strong enough, for 
example in the field of bone constructs (Table 1).  
Examples will be explored further in section 4. 
 
2.4. Inkjet printing 
Inkjet printing is a droplet-based method, relying on 
ejection of a small volume of bioink (around 20 µl) via 
a thermal, piezoelectric, electrostatic or electro-
hydrodynamic actuator (Fig. 3C). All these types of 
actuators yield droplets thanks to the surface tension 
properties of the bioink. It is possible to print cells in 
culture medium, as this technique allows the 
handling of low viscosity inks (3-12 mPa/s).38 By 
contrast, highly viscous bioinks cannot be printed. On 
reaching the receiving substrate, the bioink must 
undergo fast gelation to avoid spreading. Inkjet 
printers afford a very good resolution (20-100µm)35 
and proceed fast (1–10,000 droplets/s)22 using low 
bioink quantities. This rapidity is reached at a lower 
cell viability cost than other technologies, because of 
the relatively traumatic expulsion of cells. In addition, 
this technique remains limited to the realization of 
relatively thin 2D objects like skin substitutes and 
coatings, even when they can be composed of 
several different printed bioink layers (Table 1).38,39 
 
2.5. Laser-assisted printing 
The term ‘laser-assisted printing’ comprises several 
techniques such as laser-induced forward transfer 
(LIFT),40–42 laser-guided direct writing (LGDW),43,44 
femtosecond-laser based printing,45 and selective 
laser sintering (SLS). However, only LIFT will be 
described here because to date it is the only laser-
assisted technology that has been used to 3D print 
cells embedded in a hydrogel. LIFT printers are quite 
expensive devices. The technology relies on a laser 
beam that will go through a laser-transparent slide 
coated with a laser absorbing layer (gold or titanium) 
and a cell suspension, to eject droplets of the cell 
suspension toward a receiving substrate (Fig. 3D). To 
be printed with laser technologies, a bioink needs to 
adhere to the absorbing layer, with a low surface 
tension (80 mN/m seems to be the upper limit used 
for instance), and a low viscosity (1-300 mPa/s).22 
This technique allows a high resolution (40-300µm)41 
with a high cell viability, but with moderate speed 
(<10 droplets/s) compared to inkjet printing.41 It is 
also devoted to 2D printing of thin layers and is very 
often used to print cells alone in buffer (Table 1).43 
LIFT, like ink-jet printing, is not compatible with 
heating and cooling during droplet ejection, but may 
be equipped with a Peltier receiving plate when 
heating/cooling is required. Interestingly, it can be 
used for direct bioprinting on the body surface 
(animal or human).46 
2.6. Stereolithography apparatus (SLA) 
SLA uses a laser or a UV/visible light source to cross-
link a bioink on the surface of a vat filled with uncured 
liquid bioink (i.e. an aqueous suspension of polymer 
and photo-initiator) containing the cells. A platform 
supports the first layer of printed material and goes 
down to allow a new layer to be photo cross-linked 
(Fig. 3E). The resolution is high (< 100 µm)4 and the 
process is fast (< 1h for a few cm scaffold). Despite 
the low cost of the printer, this approach can be 
expensive, as it requires a large amount of bioink 
solution in the vat. The presence of a non-toxic 
photo-initiator is required and the bioink should 
display suitable viscosity and density to avoid cell 
decantation during the printing process. Conversely, 
there is no upper limitation to the viscosity (Table 
1).47 An alternative to SLA is digital light processing 
(DLP). While SLA photo polymerization is performed 
using a laser beam in movement, DLP is done by an 
image flashed with a projector. It allows faster 
printing of layers but requires a different apparatus. 
Table 1 Comparison of the different 3D printing techniques.48–51 
Extrusion Fused Deposition Modelling Inkjet Laser-assisted Stereolithography 
Ink viscosity (mPa/s) <  6*107 melting 3-12 1-300 No limitation 
Ink requirements Shear-thinning, shape 
retention 
Low melting temperature Rapid gelation  Low surface tension Viscosity improved to reduce 
cell decantation, photo 
cross-linking 
Cell density No limitation No limitation Low (<106cells/mL) Medium (< 108cells/mL) No limitation 
Amount of bioink needed Medium  Medium  Low  Low  High  
Processing speed Fast (< 15 cm/s) Fast (< 20 cm/s) Fast (< 10,000 droplets/s) Medium (< 10 droplets/s) Fast (< 1h) 
Resolution Moderate (> 100 µm) Moderate (> 100 µm) High (20-100 µm) High to medium (50-300 µm) High (< 100 µm) 
Printer cost Medium Low Medium High Low 
Current application 
Shaping of 10 cm scale 
scaffold 
Shaping of 10 cm scale 
scaffold 
Shaping of cm scale scaffold Shaping of mm scale 
scaffold; printing of cells 
alone 
Shaping of 10 cm scale 
scaffold 
3. Nature of bioink components
Fig. 4 Bioink composition possibilities before and 
after gelation. 
Because of the variety of printing technologies and 
applications, there is no generic bioink recipe. The 
only common feature is that bioinks are 
multicomponent aqueous mixtures (Fig. 4) that 
contain cells. After gelation, they can produce 
physical hydrogels or chemical hydrogels. The 
cohesion of physical hydrogels is maintained by 
reversible interactions such as hydrogen bonds, ionic 
and Van der Waals interactions, while covalent bonds 
(usually irreversible) lock the 3D network of chemical 
hydrogels. Surprisingly, the number of compounds 
used to make bioinks is quite limited, most of the 
studies being based on new applications of well-
known bioinks, and using combinations of these 
components. Studies presenting new compounds as 
bioink components remain quite rare. One 
explanation is that it takes a long time to 
demonstrate without any doubt good 
biocompatibility of a new biomaterial, and to obtain 
a widespread agreement among the scientific 
community involved in biofabrication. Bioink 
composition must be carefully chosen, depending on 
the desired properties of the target scaffold and also 
on the printer used (Fig. 2). This section recapitulates 
all hydrogel components that have been used to date 
for 3D bioprinting, classified according to their origin. 
The gelation process and applications will be treated 
in the section 4. 
Network precursor 
Besides 2D printing of cell layers that can be 
performed in buffers, bioinks include at least one 
network precursor, normally a functionalised 
polymer. This is the main ingredient, which provides 
consistency to the material and gives it its biological 
and mechanical properties (cell adhesion, 
proliferation, differentiation, robustness, flexibility, 
degradation, etc.). Two categories of network 
precursors can be distinguished: natural 
biomacromolecules, extracted from natural sources 
(plants, bacteria, genetically engineered cells, 
animals, etc.), and synthetic polymers. The latter 
mainly come from the chemical industry (e.g. 
Pluronic, polyethylene glycol, polycaprolactone). 
Natural polymers are extremely interesting bioink 
components as they display a superior 
biocompatibility compared to synthetic polymers. 
The main groups are polysaccharides (e.g. alginate, 
chitosan, agarose) and proteins (e.g. collagen, fibrin). 
They can be used unmodified or chemically modified 
to tune their properties or to facilitate their further 
cross-linking (e.g. methacrylated gelatin, thiolated 
hyaluronic acid). The modification of natural 
molecules usually results in improving the physical 
properties of the final material like higher and 
stronger reticulation resulting in a slower 
degradation and higher robustness. However, 
natural polymers present some drawbacks. First, 
they lack the reproducibility of synthetic polymers 
and are often more difficult to functionalize than 
their synthetic counterparts. Moreover, some 
natural materials extracted from animals, 
successfully used in 3D bioprinting, will never cross 
the barrier of clinical trials precisely because they 
raise safety concerns. This is the case of MatrigelTM, a 
complex extracellular matrix produced by murine 
cancerous cell lines (see part 3.1.). 
Doping agents, additives and delivery systems 
Components that do not contribute to scaffold 
integrity but affording additional properties can be 
used. To induce cell differentiation, growth factors 
can also be added to the bioink, simply mixed52–56 or 
chemically linked to the network.57–59 Doping agents 
such as nanoparticles (e.g. hydroxyapatite60–64) give 
robustness and can also improve cell differentiation 
into osteoblasts. Finally, micro carriers can be added 
for drug and growth factor delivery.65 They will be 
discussed in section 3.3. 
 
Complex structures 
Composite constructs can also be prepared by 
combining a bioink with a polymeric scaffold. The 
latter serves to support the bioink, improving the 
toughness of the construction. Heterogeneous layer-
by-layer printing is a way of achieving the desired 
properties as for making cell co-cultures. These 
structures will be explored in section 3.3. 
 
3.1. Natural compounds as network precursors 
Many natural high-weight biomacromolecules can be 
used as bioink network precursors. The most popular 
proteins are collagen, fibrin, gelatin and silk. In the 
polysaccharide family, alginate, gellan gum, agarose 
and hyaluronic acid are used for bioprinting with 
variable occurrences. Finally, decellularized 
extracellular matrix extracts) such as MatrigelTM and 
self-prepared extracts are also used.  
Collagen refers to a family of fibrillary proteins whose 
structure is organised in triple helices of polyproline-
II (PP-II) type. Its primary structure is mainly 
composed of repeated tripeptide motives (Gly-X-Y), 
with X and Y being mainly proline, hydroxyproline, 
lysine, hydroxylysine and alanine. Its molecular 
weight ranges from 100 to 300 kDa. Collagen is the 
major protein component of the extracellular matrix 
(ECM). Collagen type I is by far the most used for 
biomedical applications and bioprinting because it 
represents 90% of the collagen present in the human 
body, mainly in skin, bones, tendons and organs. It is 
extracted from animals, usually rat tail, or can be 
produced by recombinant bacteria. With its highly 
hierarchized and organized structure, extracted 
collagen must be treated to yield liquid 
homogeneous solutions suitable as bioinks. This is 
achieved by enzymatic or acidic treatment. The latter 
is often preferred over enzymatic treatment because 
pepsin cleaves amino acids from the C and N terminal 
regions of tropocollagen, which normally contribute 
to trigger re-assembly in fibrils. Collagen presents no 
cytotoxicity, good cell adhesion, can be biodegraded 
by collagenase, is easy to prepare, and can make a 
hydrogel at low concentration (from 1.5 
mg/ml).48,50,66 
 
Gelatin is a derivative of collagen, extensively used in 
the food industry, and a common network 
component of bioinks. Gelatin is obtained by 
prolonged boiling of bones and conjunctive animal 
tissues (bovine and porcine origin), which denatures 
the collagen organisation resulting in defibrillation 
and loss of the triple helix structure (Fig. 9). Its 
molecular weight goes from 100 kDa to 20 kDa 
depending on the product used. Once solubilised in 
water, gelatin gives a physical hydrogel once cooled 
to room temperature. It presents no cytotoxicity, 
good cell adhesion, faster biodegradability than 
collagen, is easy to prepare, and is very cheap, thus 
being a good candidate for bioprinting. Its properties 
can be improved once chemically modified (see 
3.3.).48,50 However, since the protein is shorter and 
much less organized than collagen, it needs a higher 
concentration to gelate (from 10 mg/ml).66 
 
Fibrin is a fibrous protein obtained by thrombin-
catalysed polymerization of fibrinogen (~340 kDa) 
during blood clotting.67 It has good cell adhesion, it is 
biodegradable, and is not very stable in the long 
term. Fibrin may induce an inflammatory response in 
some cases, or a thrombus. Pairing of fibrinogen and 
thrombin is particularly useful as a two component 
bioink which may gelate once in contact (see 
4.2.3.1.).48,50 
 
Silk is a protein-based biomaterial produced by 
worms (commercially), which can be use as a bioink 
precursor. Silk is formed by fibroin proteins (100-450 
kDa) with inter and intra strand beta sheet structures 
(Fig. 5E). To be used as a bioink, silk needs a 
treatment before gelation consisting in breaking H-
bonds between sheets to be solubilized. Silk-based 
bioinks present good cell adhesion and 
degradability.68 
 
Alginate is the most used biopolymer for bioprinting. 
This polysaccharide (Fig. 5A) is extracted from brown 
algae. It is composed of β-D-mannuronate (1.4)-
linked to C-5 epimer α-L-guluronate, with a molecular 
weight varying from 10 to 200 kDa. It is 
biodegradable, biocompatible and induces no 
inflammatory response but presents a relatively 
modest cell adhesion compared to other 
biopolymers.69 Its most attractive feature lies in the 
very simple way gelation is triggered, by the addition 
of a non-toxic divalent cation (e.g. Ca2+). It can reach 
different viscosities depending on concentration, 
allowing alginate to be printed with various 
instruments.48,50 
Gellan gum is an anionic polysaccharide (Fig. 5B), very 
close to alginate in terms of implementation (cation-
triggered gelation) and physico-chemical properties. 
It is a tetrasaccharide consisting of two D-glucose 
units, one of L-rhamnose and one of D-glucuronic 
acid, with an average molecular weight of 500 kDa. 
This polysaccharide is extracted from the 
Sphingomonas elodea bacteria and gives a 
transparent hydrogel. Like alginate, gellan gum 
presents very poor cell adhesion compared to other 
natural polysaccharides used as bioinks.48,50,69–71 
Hyaluronic acid (HA), also known as hyaluronan, is a 
glycosaminoglycan extracted from bacteria 
(genetically modified Bacillus subtilis) (Fig. 5C).  It is 
constituted of an unbranched disaccharide 
repetition unit composed of D-glucuronic acid and 
D-N-acetylglucosamine. Several HA formulations
have been approved by the FDA. HA is a major
component of the human extracellular matrix, giving
elasticity and hydrophilicity to tissues, and therefore
displays very good cell adhesion, biocompatibility
and biodegradability by hyaluronidase.72,73
Nevertheless, to obtain a HA-based hydrogel, it must
be used at high concentration (> 2 mg/ml) or to be
chemically modified.48,50 In the body, it can have a
molecular weight varying from 10 to 10000 kDa
depending on its origin, and it is commercially
available in many sizes.
Cellulose is a biopolymer made up of D-glucose units. 
It comes from plants and wood. Cellulose by itself 
does not yield hydrogels. However, methylcellulose 
(Fig. 5D), nanocellulose (nano-sized cellulose fibers) 
and other cellulose derivatives are suitable for 
hydrogel’s formation. They are obtained by chemical 
modifications of cellulose. Although cellulose is 
biocompatible, it presents low cell attachment 
properties and is non-degradable by human cells.74 It 
is mainly used as a supporting material for other 
bioinks.48,50,74 
Agarose, a seaweed-extracted polysaccharide, with 
D-galactose and 3,6-anhydro-L-galactopyranose 
repetition units, (~120 kDa, Fig. 5F) is commonly used 
in molecular biology to make hydrogels. Agarose is 
easy to print but unfortunately suffers from a low cell 
attachment although it is biocompatible and can be 
degraded by cells.75 
Decellularized containing extracellular matrix (dECM) 
can be used as bioink. These complex protein 
mixtures can be obtained from any cell culture in 
laboratory, using specific protocols (extraction from 
native skin,76, heart tissues,52 adipose tissue and 
cartilage).52,77,78 dECMs include structural proteins 
like collagen, laminin and nidogen, but also growth 
factors and small quantities of other proteins. Thanks 
to its inherent properties, ECM components and 
growth factor cocktails are highly favourable for cell 
proliferation and differentiation, and to its viscosity, 
from 106 mPa/s in non-diluted state and lower after 
dilution, they are very attractive bioactive and easy-
to-print bioinks. However, dECMs are physical 
hydrogels presenting low elasticity and stiffness.48,50 
Among dECMs, MatrigelTM is a commercially 
available bioink. It is produced by a mouse sarcoma 
cell line (Engelbreth-Holm-Swarm, EHS) and 
marketed as support for cell culture. The complex 
composition of MatrigelTM is one of its major 
advantage as it recapitulates the features of natural 
ECMs.79,80 The downside of dECM, including 
Matrigel, is that these materials are not 
quantitatively and even qualitatively defined and 
display significant variability between batches. 
Despite its popularity and efficiency for cell culture, 
MatrigelTM remains a support for bioassays, and it is 
very unlikely that such a material could one day be 
injected in humans, for safety and ethical reasons 
(i.e. infection, immunogenicity).48,50 
 
Fig. 5 Biopolymers used as bioink components: (A) 
alginate, (B) gellan gum, (C) hyaluronic acid, (D) 
methylcellulose, (E) silk fibroin, and (F) agarose. 
As mentioned before, biomacromolecules can also 
be chemically modified, keeping their inherent, 
interesting properties, and adding new ones. Some 
do not gelate and cannot be used as a bioink. They 
must be reticulated to form a hydrogel network. 
Chemical modifications can also afford additional 
properties (e.g. speedy gelation, slow degradation, 
possibility of backbone grafting of other active 
molecule-modifying rheological properties). 
Chemical modifications of biopolymers will be 
presented in section 4.2.1. 
3.2. Synthetic compounds as network 
precursors 
Mostly bio inert and displaying poor cell viability 
compared to natural biopolymers, synthetic 
polymer-based bioinks must be supplemented by 
other components. They may also serve as supports 
and intercalated layers in composite materials, to 
improve the mechanical properties of the final 
constructs. 
Poly(ethylene glycol) (PEG, Fig. 6A and 6B) is FDA 
approved and displays good biocompatibility. 
However, it is poorly adherent to cells and lacks 
biodegradability.50,81 It is commercially available in 
several shapes, in linear or branched geometries (3, 
4, or 8 arms), and in various sizes from 0.5 to 20 kDa. 
To be used as a hydrogel, it needs to be cross-linked 
(see 3.3.). 
Polycaprolactone, polylactic acid and copolymers of 
them82 (PCL, PLA, poly(lactide-co-caprolactone, PLCL 
Fig. 6C, D and E respectively), like polyesters, 
cannot be used to encapsulate cells, as they are 
water insoluble plastics.50 However, they are 
biocompatible and they represent interesting choices 
as cell-free supporting materials. The ester linkage 
can be degraded slowly by lipase and esterases. The 
reported degradation time of PLA ranges from 10 
months to 4 years, depending on the size83 and of the 
porosity. It may be even longer for PLCL, yielding 
hydroxyhexanoic acid and lactic acid. Thus, a bioink 
used in alternation with these polyesters will likely be 
degraded long before it, increasing the scaffold’s 
stiffness during the life of the hydrogel. PCL and PLA 
have been approved by the FDA for the preparation 
of medical devices (e.g. implants for drug delivery, 
screws and plates).84 They are stiff, biocompatible 
and cheap materials that can be extruded by FDM 
at their glass transition temperature is of 60 °C for 
PCL50,85,86 and of 65°C for PLA.87,88  
Pluronic F127 (x = 110 and y = 70, 12.5 kDa, Fig. 6F) is 
a poloxamer, which is principally used as a sacrificial 
ink when suspended in an aqueous solution. It 
undergoes a temperature-dependent sol-gel 
transition, being liquid below 10 °C, and gelifying at a 
higher temperature. At low temperature, pluronic is 
present as a unimer state. It forms micelles by 
desolvation of hydrophobic chains, which interact 
with each other to yield the hydrogel network when 
the temperature rises up. Its good water solubility 
and thermos-responsiveness make pluronic 
particularly attractive to use as a sacrificial ink. 50,89,90 
Indeed, once shaped at low temperature, pluronic 
printed areas can be easily removed by water 
washings.50,89,90 This is particularly useful when long 
gelation times of other bioinks are required, as it 
serves as a temporary supporting matrix. It may be 
used to create holes in the final material for vessel 
printing. Another smart use of pluronic is to reduce 
the toxicity of some compounds (catalysers or cross-
linkers) which are required for bioink gelation by 
adding it inside the pluronic layer instead of the 
bioink.64,65,91 Compounds migrate slowly from the 
pluronic to the bioink, being present at lower 
concentration and over a longer period of time than 
if they were simply mixed with the bioink, thus 
reducing the toxicity and improving cell survival.(Fig. 
7D). 
Fig. 6 Synthetic polymers commonly used as inks: (A) 
polyethylene glycol; (B) 4 arm-PEG; (C) 
polycaprolactone; (D) polylactic acid; (E) polylactide 
co-caprolactone; and (F) Pluronic F127. 
3.3. Composite and complex constructs 
As just discussed, printed scaffolds may sometimes 
be advantageously composed of two or more 
different inks, where at least one is a bioink. These 
complex constructions could be classified in three 
categories:  
 Composite structures with alternating bioink
and plastic (i.e. dry polymeric material) layers,
the latter being merely a rigid backbone
structuring the scaffold;
 Heterogeneous structures obtained by printing
different bioinks/ink layers of different
compositions;
 Complex structures in which various objects are
included in the bioink. These may be nano-
carriers for drug delivery, nanoparticles or
chemicals.
It is worth noting here that we do not consider 
‘complex constructs’ scaffolds obtained by 
alternating layers containing or excluding gelation 
catalysts (e.g. photo initiators, CaCl2). 
Composite structures 
The rigid part of these scaffolds is always made from 
PCL and PLA printed by FDM or regular extrusion, 
heating at glass transition or melting temperature. 
This structure can be used as a mold circling the 
hydrogel to prevent flooding, or as tougher layers in 
between bioink layers (Fig. 7A, B and C). This 
procedure is extensively used to produce bone and 
cartilage grafts where PCL or PLA layers are combined 
with alginate, agarose, gelatin or MatrigelTM 
bioinks,53,54,60,92–96 and has also proved to be useful 
as a robust cell culture platform.97 The plastic and the 
bioink are usually extruded with a multi-head printer. 
Heterogeneous structures 
The most common heterogeneous structures are 
obtained by printing successive superimposed layers 
(2 or 3), each composed of a different bioink. Each 
bioink can contain specific cells, but may also include 
different network precursors. For example, a cross-
linker or a reticulation agent (cation, enzyme, photo-
initiator, etc.) can be included in a different ink 
(typically Pluronic) than the one containing the 
network precursor. However it can also be used in 
two-step cross-linking, for example fast physical 
gelation followed by chemical cross-linking, to 
change the physical characteristics of the hydrogel 
(degradation, rheology, etc.). As already stated, one 
of the inks can be a temporary template removed 
after printing (Fig. 7 D and E). The removal of the 
sacrificial ink must be as simple as possible without 
inducing the structure collapse. Tubes have been 
printed by coaxial extrusion of Pluronic (inside) and a 
mixture of alginate and dECM embedding cells 
(outside) to generate blood vessels.65 Alternatively, 
sacrificial ink has also been used to support gelatin 
methacrylate-encapsulating cells during the 
proliferation and differentiation of the co-culture. 
Pluronic, which supported the bioink deposition, was 
removed once the cells had created their own ECM, 
yielding a biomaterial stiff enough to keep its 
structural integrity.10 
Both the two strategies, cell co-culture using two 
different bioinks, and the use of sacrificial ink to make 
hollow structures, have been combined to create 
vascularized tissue constructs.98 
Complex structures 
This category includes two groups of compounds, 
nanomaterials and chemicals that display various 
new properties.   
Complex constructs can be obtained by doping an ink 
or a bioink with nano objects. This is mainly used to 
improve the physical and biological properties of the 
hydrogel. Gold nanorods were added to give 
electrical properties and to improve cell signalling 
between cardiac cells.99 Introduction of micro-
carriers gives higher compressive strength100 and 
allows delivery of drugs and growth factors.65 Organic 
and inorganic nanoparticles are used to improve cell 
differentiation (e.g. hydroxyapatite60–64). and 
stiffness.101,102 Spheroids, i.e. small spheres of 
hydrogel containing cells inside, can also be added to 
have a different cell distribution inside the 
scaffold.103 
Addition of chemicals into bioinks can tune their 
properties. Hydrogel physical properties can be 
modified by adding polyvinylpyrrolidone (PVP), a 
macromolecule giving a “high fractional volume 
occupancy” (FVO) to enhance the excluded volume 
effect. This results in high volume pores into the 
hydrogel, thanks to its high size.104 Studies have 
demonstrated that the addition of PVP into bioinks 
improved its homogeneity, as well as the viability of 
printed cells during and after bioprinting. 
On the other hand, the hydrogel can be covalently 
modified by bioactive molecules. It can be modified 
with substrates of matrix metalloproteases (MMP), 
which are used as spacers by linking two different 
polymeric network precursors. Upon MMPs release 
by cells from the culture, the peptide sequence is 
cleaved, specifically releasing the network and 
decreasing the degradation time.57,58 It is also 
possible to add drugs,60,65 peptide ligands improving 
cell adhesion like the integrin ligand RGD57–60,105,106 
and differentiation factors.54 In these cases, the 
bioink itself acts as a reservoir for drug/bioactive 
compound delivery. The design of hydrogels to 
deliver fragile bioactive ingredients such as 
therapeutic proteins or peptides, in a time and 
spatially resolved manner is a very important field of 
research, and the subject of comprehensive recent 
reviews.107–112 Studies carried out in this area will 
undoubtedly cross-fertilize the field of biofabrication. 
Fig. 7  Printing of composite scaffolds containing a plastic support ink (A54,96,113,114, B5,53,60,77, and C52,95), and 
examples of  heterogeneous scaffolds containing at least two non-plastic (bio)inks (D115–117 and E10,91).  
4. Physico-chemistry of gelation
Depending on the nature of the network precursors, 
a bioink can turn into a physical or a chemical 
hydrogel. As explained earlier, the integrity of a 
physical network is stabilised by weak interactions. 
In the case of a chemical hydrogel, the gelation 
occurs upon establishment of covalent bonds formed 
between reactive groups present in the network 
precursors (e.g. polymers) and/or additional bi- or 
multi-functional cross-linkers. In all cases, 
physicochemical parameters such as temperature 
and concentration of precursors have an impact on 
the gelation kinetics, on the final appearance and 
properties of the printed hydrogel scaffold. The 
following parts of this review describe the different 
gelation physical or chemical processes and the main 
classes of network precursors. All the reviewed 
examples will also be presented in three tables 
(Tables 2 to 4) at the end of this review, sorted by the 
mechanism of gelation used. 
4.1. Non-covalent assembly (i.e. bioinks based 
on physical hydrogels) 
The physical assembly of molecules and 
macromolecules into a hydrogel by non-covalent 
bonds is generally reversible. Thanks to shear-
thinning (i.e. thixotropic) properties, the hydrogel 
can go back to a liquid state upon compression or 
stirring, simplifying the 3D printing process. Physical 
hydrogels containing bioink are easy to prepare and 
numerous network precursors are commercially 
available, allowing gelation after solubilisation. 
Gelation is fast and biocompatible; it generates no 
side product and does not require any additional 
chemical reagent (e.g. photo initiator, coupling 
reagent) with the exception of ions in the case of 
ionotropic gelation. The downside is that physical 
hydrogels undergo a faster degradation compared to 
chemical hydrogels, and present relatively weak 
mechanical properties. It implies that they cannot be 
used for long-term scaffolding. However, they 
present good self-healing post printing properties 
with no mark of extrusion, no interfacial area, etc., 
and low shear stress, compatible with all 3D-
bioprinting technologies except stereolithography, 
which needs covalent UV cross-linking (see 4.2.2.). 
Among the physical gelation driving forces, one can 
distinguish weak inter- and intra-molecular 
interactions such as self-assembly, aggregation and 
coacervate, and ionotropic gelation (Fig. 8). All 
examples are assembled in Tables 2 (physical 
gelation-based bioinks) and 4 (complex bioinks). 
Fig.  8 Gelation process of physical hydrogels: self-
assembly-driven gelation, coacervate and ionotropic 
gelation. 
4.1.1. Weak binding forces (coacervate 
gelation, self-assembling, etc.) 
Self-assembling of network precursors, through 
hydrogen-bonding, π-stacking, hydrophobic and 
van-der-Waals forces, can give a suspension viscous 
enough to yield to a printable material (Fig. 8). The 
nature of these forces depends on chemical formula 
of the network precursor (i.e. the biopolymer). When 
there is a specific recognition of sequences, we talk 
about self-assembly, whereas when it is just 
assembly by weak binding without specificity we talk 
about aggregation. Coacervate is made by 
combination of attractive forces between 
biopolymer chains, but mainly by repulsive 
hydrophobic interactions with the solvent, leading to 
gelation. Common physical bioinks are collagen, 
hyaluronic acid and gelatin, which can turn into a 
hydrogel by formation of hydrogen bond networks. 
 dECM-based bioinks 
The poor physical properties of decellularized 
extracellular matrices are counterbalanced by the 
high cell viability observed within such materials after 
3D printing. dECM suspension into PBS or culture 
medium (10-30 g/l) gives a viscous hydrogel 
principally by self-assembly. These hydrogels have 
been used for 3D bioprinting alone by extrusion or 
combined with a PCL printed framework77 to 
circumvent its poor Young’s modulus.  
Li et al.118 mixed Matrigel™ with various 
concentrations of hydroxypropyl chitin to extrude it 
with moderate heating (15-37 °C). Murphy et al.113 
extruded droplets of Matrigel™ bioink on the top of 
PCL layers containing 13-93B3 borate glass, which 
promote angiogenesis. 
 Collagen-based bioinks 
Commercially available collagen can be provided as 
lyophilized fibrous material, or more conveniently, 
already solubilized in acidic solution (HCl or acetic 
acid, pH ≈3) at 1 to 10 mg/ml. At low pH, peptide 
chains are globally positively charged. The PP-II and 
the tropocollagen triple helical assembly are 
conserved, but repulsive forces arising from charge 
repulsion disturb the self-assembly of fibers, 
resulting in a homogeneous liquid solution mostly 
composed of isolated tropocollagen. This stock 
solution is then poured into neutralizing buffer (e.g. 
PBS with sodium hydroxide). After about 30 minutes 
at 37 °C, a hydrogel is obtained thanks to the re-
assembly of fibrils and then fibers. This assembly is 
driven by hydrogen bonding between amino acids 
belonging to different collagen chains and steric 
constraints. 
Fig.  9 Hierarchical assembly of collagen into fibrils and fibers in acidic solution upon neutralization. 
At low concentrations (< 1 wt%) collagen is suitable 
for droplet ejection,119 inkjet104 and laser-assisted 3D 
bioprinting.46 At higher concentrations (above 1.25 
wt %), it reaches a viscosity suitable for extrusion.120 
 Hyaluronic acid-based bioinks 
Thanks to intermolecular hydrogen bonding and 
strong interactions with water molecules, hyaluronic 
acid can turn into a viscoelastic hydrogel with 
random coil organisation and lubricant properties.73 
It can be used alone, but it is more commonly used in 
combination with another biomacromolecule (e.g. 
methylcellulose) to improve the physical properties 
of the bioink mixture by reducing the swelling for 
extrusion. 
Silk-based bioinks 
Silk fibroin has the ability to undergo sol-gel 
transition in water under stimulated conditions 
(shearing, solvent removal, heating, sonication, 
addition of salts, etc.).121 This is due to its propensity 
to form intra- and inter-molecular antiparallel β-
sheet structures, thanks to hydrogen bonding 
between C=O and NH groups of amides in the Ser-
Gly-Ala structure (Fig. 10). Indeed, β-sheets are 
dynamic structures privileged when self-assembly is 
induced by increased concentration, heating or 
addition of other aggregation and self-assembly 
inducing compounds. Interestingly, the sol-gel 
transition can be also provoked by addition of 
polyethylene glycol chains. This Fibroin/PEG mixture 
has been used as a bioink for extrusion.122 
Fig. 10 Self-assembly of silk fibroin peptide sequences 
in antiparallel β-sheet structure. 
 Agarose-based bioinks 
At low temperature, usually below 45°C, but it can be 
lower depending on the different chemical structures 
and molecular weights of agarose that are used, 
agarose solutions undergo a thermic hysteresis 
liquid-solid phase transition, leading to hydrogels 
formation thanks to intra- and inter-molecular 
hydrogen bonds, giving double stranded helices and 
water retention inside the hydrogel cavities (Fig. 
11).123 Because of its low cell attachment property, 
agarose is often mixed with collagen.100 It has also 
been combined with short dipeptide gelators that 
self-assemble (e.g. Fmoc-diphenylalanine and Fmoc-
isoleucine-glycine), and collagen for droplet ejection 
into an oil vat.124 An emulsion is formed by 
organization of a lipid monolayer around the bioink 
droplet (Fig. 12). A mixture of agarose and collagen 
has also been used along cell-laden poly(D,L-lactic-
co-glycolic acid) (PLGA) porous microspheres,100 
yielding a complex bioink with improved compressive 
resistance and cell viability suitable for extrusion. 
 
Fig. 11 Gelation process of agarose. 
Fig. 12 3D bioprinting of bioink composed of 
agarose, dipeptides and collagen, into an oil vat (from 
ref 124). 
 Thermo-sensitive bioinks 
Thermo-sensitive polymers have the ability to change 
from a sol/coil state to a gel state by aggregation (e.g. 
for PNIPAM compounds) or formation of micelles 
(e.g. for Pluronic and other poloxamers, Fig. 13) with 
temperature increase, upon reaching the lower 
critical solution temperature (LCST).125 Indeed, when 
the temperature is above the LCST, the hydrophobic 
part of the polymer aggregates to form micelles and 
the hydrophilic part dehydrates, leading to 
aggregation of micelles, and to a viscosity increase. 
Fig. 13 Thermo-sensitive polymer structure 
transition. 
Lorson et al.126 developed block copolymers made by 
ring opening polymerization of hydrophilic poly(2-
methyl-2-oxazoline) and thermos-responsive poly(2-
n-propyl-2-oxazine) (nPrOzi) (Fig. 14) that have been 
used in solution. The block copolymer solution 
becomes a hydrogel at temperatures higher than 30 
°C, which is quite useful for 3D printing cells at 37 °C 
by an extrusion process. Indeed, while passing 
through the nozzle, the bioink is liquid but turns into 
a gel once in contact with the heated collector 
surface. 
Fig. 14 Block copolymer synthesized by ring opening 
polymerization of poly(2-methyl-2-oxazoline) and 
poly(2-methyl-2-oxazine).126 
With a similar strategy, Hsieh et al.127 developed a 
thermos-responsive bioink (i.e. gelation above 37 °C) 
containing stem cells, adapted to extrusion printing. 
They used an aqueous suspension of nanoparticles 
made out of two different polyurethane (PU) 
derivatives, a copolymer of poly(ε-caprolactone) 
(PCL) diol that provides soft properties, and poly(L-
lactic)acid (PLLA) diol or poly(D,L-lactic) acid (PDLLA) 
diol, with incorporation of isophorone on the 
polymeric chain and of a urethane bond in-between 
(Fig. 15). These PU are biodegradable and their 
rheological properties can be tuned by variation of 
the PU derivative concentration. Moreover, the 
crystal structure of PLA, which is dictated by its 
conformation, has an influence on both cell 
proliferation, which is better for PDLLA-containing 
PU, and differentiation, which is better for PLLA-
containing PU. The hydrodynamic diameter of the 
particles increases from 34-38 nm at 10 °C to 44-48 
nm at 37°C, due to heating-induced swelling.128 The 
diameter increase also allows negative charges to be 
pushed away from the surface of the NPs, decreasing 
repulsion between them, and leading to aggregation 
of NPs to form a hydrogel. 
Fig. 15 Precursor of nanoparticles giving thermos-responsive bioink, nanoparticles and gelation upon 
heating.127 
Peptide- and DNA-based 
bioinks 
Thanks to the diversity of amino acid side chains, to 
the hydrogen bonding properties of the amide bond, 
and to the variety of secondary structures of 
peptides, many peptide sequences are able to self-
assemble through non-covalent interactions such as 
hydrogen bonds, π/π stacking, and hydrophobic 
interactions, leading to the formation of supra 
molecular structures. β-sheet forming peptides are 
among the most widely studied for hydrogel 
formation,129,130 especially in the field of drug 
delivery,131 but some of these peptides have been 
recently used as bioink components. Upon reaching 
a sufficient concentration and depending of the 
peptide's structure, they form fibrils that grow in a 3D 
network of entangled fibers, turning the solution into 
a physical hydrogel. This is the case for Gly-Ala-Ile-Leu 
from 17 wt%, to 0.01 wt% for PTZ-Gly-Phe-Phe-
Tyr.129 Commercially available β-sheet-forming 
peptides were already available for extrusion 
bioprinting (e.g. from PeptiGelDesign).132 On the 
other hand, amphipathic peptides bearing a 
hydrophobic N-terminus and a cationic hydrophilic C-
terminus (e.g. Ac-ILVAGK-NH2120) have the 
propensity to assemble in stable helical supra 
molecular structures, which induce gelation in less 
than 10 seconds at 37 °C in the presence of cells. 
Bioinks based on short peptides are fully synthetic 
and do not suffer of natural biopolymer problems like 
batch-to-batch reproducibility. Moreover, they are 
easy to modify, and to add additional properties to 
the network. Unfortunately, they form physical 
hydrogels whose mechanical properties are not 
easily tuned, and they can be quite expensive 
especially when large volumes of scaffold have to be 
printed.  
A few bioinks have been developed on the basis of 
oligonucleotide sequence specific recognition. For 
example, Li et al.115 proposed a bi-component bioink 
made of a polyGlu–DNA conjugate and a double-
stranded DNA (dsDNA). The two components are 
deposited alternatively by inkjet printing with high 
accuracy. Upon diffusion, the fast hybridization of the 
polyGlu-DNA conjugate and the dsDNA (Fig. 16) 
yields a hydrogel with good self-healing properties. It 
is noteworthy that this hydrogel can undergo 
enzymatic degradation by peptidases and nucleases. 
Fig. 16 3D bioprinting of a two components bioink 
using DNA hybridization strategy. Poly(L-glutamic 
acid240-co-g-propargyl-L-glutamate20) in purple, 
single strand DNA conjugate in blue, double stranded 
DNA in red.115 
The property of guanosine to form tetrameric 
assemblies in water, in the presence of monovalent 
cation such as potassium or sodium (i.e. G4-quartet 
structure), was exploited by Biswas et al.133 to 
develop a bioink. Indeed, tetramers stack on the 
top of each other to from nano-fibers, which 
entangle in a 3D network. This hydrogel is highly 
thixotropic and has self-healing properties allowing 
its easy extrusion providing good cell viability. 
Host-guest interaction-driving 
gelation 
Host-guest chemistry is driven by self-recognition 
and non-covalent interactions between two 
chemical entities (e.g. a receptor and a ligand) 
forming an extremely strong and stable complex. 
An example of host-guest interaction is the 
assembly of cucurbituril, a macrocycle made of 
glycoluril units bound together by methylene 
bridges, with alkyl chains inside its hydrophobic 
cavity.134 K. Kim’s and D.-W. Cho’s teams54,135 have 
used this tandem to develop a complex construct 
using four different inks. The first ink is PCL, printed 
as a supporting scaffold for the overall construct 
made of two bioinks containing cells and two 
different growth factors, and another ink. One 
bioink is composed of collagen, and the other 
contains functionalized hyaluronic acid with the 
host [Cucurbit[6]uril-hyaluronic acid, (CB[6]-HA)]. 
Finally they extruded the forth ink, which contain 
hyaluronic acid functionalized with the guest: 1,6-
diaminohexane-hyaluronic acid (DAH-HA). The 
CB[6]-HA and the DAH-HA (Fig. 17) assembled 
together by a host-guest mechanism. The weak 
interactions between hyaluronic acid chains 
improve the viscosity of the construct. 
Fig. 17 Host-guest promoted gelation of HA-based 
network precursors (CB[6]-HA and DAH-HA).135 
4.1.2. Ionotropic gelation 
Ionotropic gelation is initiated by the complexation of 
a cation by several anionic moieties present within 
two or more polymer chains of the network 
precursors, thus generating strong reticulation nodes 
(Fig. 8). This is the case of alginate (Fig. 18) and gellan 
gum (Fig. 19). Bivalent cations (e.g. Ca2+) are required 
to form ionic bonds with at least two oligosaccharide 
units to create a 3D network. Advantageously, 
cations triggering the gelation can be added to the 
bioink using various strategies. Firstly, cations can be 
dissolved into the bioink before printing thus 
increasing the viscosity of the hydrogel. Secondly, 
they can be mixed within a sacrificial ink. Upon 
contact between the two ink layers, cations diffuse 
into the bioink containing the network precursors to 
covalently bind. 115–117 It is often used for co-axial 
extrusion. Thirdly, the network precursor bioink can 
be directly printed into a vat or deposited on a bio-
paper containing the cations.136–138 Upon contact, 
the bioink gelates. It is worth noting that vats are 
more adapted for extrusion or inkjet, and bio-paper 
for laser-based printing. Finally, if the printed scaffold 
is able to keep its integrity long enough without 
ionotropic cross-linking, it can be cross-linked after 
by immersion for few minutes into a vat containing 
the cations. It is generally possible with the addition 
of another biopolymer to increase the viscosity of the 
bioink.8,62,92,139–145  
 Alginate-based bioinks 
So far, about one quarter of the bioinks described in 
the literature are composed of alginate, alone92,136 or 
in combination with other biopolymers. Their 
popularity can be explained by the simplicity of the 
ionotropic gelation process, which does require 
neither chemical reagents, nor specific equipment 
(e.g. UV irradiation), and by the fact that the network 
precursor, sodium alginate, is commercially available 
and cheap. 
Fig. 18 Ionotropic gelation of alginate. 
The calcium cations bind with strong affinity to 
guluronate units of alginate chains, forming repeated 
junctions with an identical unit of an adjacent chain. 
The so-called ‘egg box model’146 is stabilized by 
evenly distributed ionic bridges formed between 
carboxylates and the divalent cation (Fig. 18). 
Natural extracts are commonly used as additives to 
alginate to give additional biological properties to the 
hydrogel. For example blood plasma8 and dentin 
extracts, containing growth factors and 
polysaccharides have been used.147 Other 
biopolymers like gelatin139,140, cellulose derivatives 
(e.g. nano-fibrillated cellulose141,142, 
methylcellulose116 and ethylcellulose143) or a 
combination of collagen and agarose144 have also 
been reported to improve the alginate properties for 
extrusion printing, mainly viscosity, reinforcing 
thixotropy and stiffness. Along the same lines, 
polyvinyl alcohol (PVA)61,62 has been sometimes 
added to improve the elasticity of the scaffold and to 
increase the resolution obtained by extrusion-based 
printing.  
Ahn et al.145 dissolved alginate in a preservation 
solution containing DMSO and salts like NaCl and 
MgCl2, commonly used to preserve cell integrity 
during freezing. It facilitated the bioprinting by 
extrusion at low temperature (-10 °C). This strategy 
delivered higher print resolution and scaffold 
porosity, unfortunately at the cost of lower cell 
viability. 
Many researchers have improved scaffold 
robustness by creating a composite construct doped 
with insoluble nano- and micro-structures. For 
example, nano-hydroxyapatite63 was added to 
alginate bioink to allow high throughput printing with 
laser-induced forward transfer. PLA-sub-micro 
fibers148 were added to a cell embedded alginate 
bioink to improve rheological properties. 
Alginate composites are also particularly useful for 
bone and cartilage engineering. Cho’s team53 used 
this strategy to print an alginate bioink alternated 
with PCL layers by extrusion. PCL was used to create 
a solid framework to improve the stiffness and the 
stress modulus of the scaffold required for these 
applications.95,96 The alginate bioink used in PCL 
composite scaffolds may also contain other 
biopolymers such as gelatin114 and nanofibrillated 
cellulose (CELLINK® from Cellink).93 PCL-alginate 
alternating layers can also be supplemented by other 
components such as nano-hydroxyapatite, plasmid 
DNA, and peptides promoting cell adhesion (e.g. 
RGD).60  
From a process point of view, alginate has been used 
to create vascularized constructs. A coaxial nozzle 
(Fig. 2A) simultaneously distributed cell-embedded 
alginate (in the shell), and a calcium chloride solution 
(in the core). This extrusion process has yielded 
tubes.149 PLGA microspheres loaded with the pro-
angiogenic drug atorvastatin have also been added 
inside the ‘shell’ bioink composed of alginate, 
collagen and vascular dECM, to create artificial blood 
vessels.65 Notably, the reverse process was also 
performed,150 i.e. alginate and cells on the core and 
calcium chloride on the shell, to print hydrogel 
ribbons with a lower quantity of salts inside the 
hydrogel and better printing accuracy. At 1% 
concentration, this hydrogel can also be inkjet-
bioprinted directly into a vat of calcium 
chloride.137,138 
Grolman et al.151 used a three level co-axial extrusion 
process developed with microfluidic capillaries. The 
core of their construct is an alginate bioink, the 
middle layer is a solution of CaCl2 containing 
macrophages, and the outer layer is a saturated 
CaSO4 solution. This process allowed them to co-
culture cells to create a micro-environmental tumour 
model. 
 Gellan gum-based bioinks 
Like alginate, gellan gum has the ability to turn into a 
hydrogel by complexation of calcium ions (Fig. 19). 
This proceeds at a lower concentration than that of 
alginate (> 1 wt% for alginate against < 1 wt% for 
gellan gum), yielding a more elastic material because 
it is less complexed by calcium. 
Lozano et al.105 developed an extrudable bioink 
based on gellan gum modified with RGD peptides. 
Carboxylic acid functions of the oligosaccharide were 
activated by carbodiimide along with sulfo-N-
hydroxysuccinimide as auxiliary nucleophile, to react 
with the N terminal amine of the RGD linear peptide. 
Ferris et al.152 used gellan gum for droplet ejection 
and inkjet.  
Kesti et al.64 mixed gellan gum, alginate and cells 
composing a bioink for extrusion in alternation with 
a pluronic-CaCl2-SrCl2 ink. Interestingly, SrCl2 induces 
higher storage modulus of the scaffold than CaCl2. 
Fig. 19 Ionotropic gelation of gellan gum. 
Catechol-vanadium-based 
bioinks 
Catechol is known to form complexes with vanadium 
(vanadyl sulfate) thanks to its ability to form 
hexavalent species. Lee et al.153 took advantage of 
this complexation to design a new system of 
ionotropic gelation. They modified the amino groups 
of chitosan through reaction with carboxylic acid of 
catechol. The resulting conjugated biopolymer 
undergoes ionotropic gelation in the presence of 
vanadium, producing an extrudable bioink (Fig. 20).  
Fig. 20 Catechol-chitosan conjugate complex with 
vanadyl (IV) ions.153 
4.2. Covalent assembly (i.e. bioinks-based on 
chemical hydrogels) 
Covalent assembly of network precursors is an 
irreversible process yielding to chemical hydrogels. 
Network precursors display mutually reactive 
functions, ideally in a chemoselective way, to cross-
link the 3D network of the bioink. The resulting 
material will not be able to transform into a liquid but 
will be degraded in a time-dependent manner, by 
spontaneous or triggered hydrolysis (e.g. pH, 
enzymes, UV…). The cells within the bioink are 
expected to produce their own extracellular matrix, 
replacing the hydrogel after its degradation. 
However the scaffold will act as a support during this 
period, for this reason the degradation rate needs to 
be controlled as fast, long or even permanent, 
depending on the targeted application. In fact, non-
covalent interactions also contribute to the overall 
gelation, covalent bonds adding a supplementary 
degree of stability to the hydrogel. 
In the same way as physical hydrogels, the precursor 
concentration must be high enough to be cross-
linked, but more importantly, it is the concentration 
of reactive functions presented by the bioink 
components that should be considered for suitable 
chemical assembly. In other words, the ratio of 
chemical modifications to unmodified motifs present 
along the biopolymer backbone is of great 
importance. To give an idea, covalent bioink 
networks can be formed by chemical modifications of 
10% to 60% residues of biopolymers, and the 
required concentration of the network precursor to 
gelate depends on its structure, which is about the 
same as for physical hydrogels. For synthetic 
polymers like PEG having reactive groups at both 
extremities, at least 5 wt% of the network precursor 
is required to reach gelation. It is possible to modify 
the physical characteristics of the material such as 
increasing stiffness, by increasing either the 
concentration of blocks, or the amount of reactive 
moieties leading to cross-linkage. Conversely, the 
more cross-linked the hydrogel, the smaller the pores 
will be. 
Bioinks made from chemical hydrogels enable 
printing of scaffolds with improved stability and 
mechanical properties, but they are not 
straightforward to use as physical hydrogels. Firstly, 
most of the commonly used network precursors 
must be chemically modified before preparation of 
the bioink to display suitable reacting groups. 
Secondly, special attention must be paid to the 
biocompatibility of the reticulation reaction itself. All 
the reactants, catalysts, solvents and products need 
to be non-toxic, as well as the reaction conditions 
(temperature, pH), which may also require specific 
printers (e.g. a heating system, a UV lamp for curing). 
These factors limit the available chemistries to a 
handful of cell-friendly reactions. All examples cited 
in this chapter are brought together in Tables 3 and 4 
(Chemical gelation-based bioinks and Complex 
bioinks). 
4.2.1. Chemical modification of precursors 
As already stated, chemical cross-linking necessitates 
prior modification of the network precursor, whether 
they are biomacromolecules or synthetic polymers. 
Many chemical modifications154 have been 
proposed, but this review will only focus on those 
that were successfully used for 3D-bioprinting. The 
most popular chemical modification of bioink 
network precursors is the introduction of vinyl 
groups. Such unsaturated moieties are prone to 
many bio-orthogonal reactions, including Michael 
addition, chain-growth photo-polymerization and 
step growth polymerization (see 4.2.2). Acrylate and 
methacrylate moieties are the most important class 
of vinyl acceptors. The second most commonly 
encountered functionalizations are thiol 
incorporation, as partners of unsaturated moieties 
for Michael additions, or to form disulphide bridges. 
Introduction of acrylate derivatives 
The functionalization of biopolymers is preferentially 
done on amine and alcohol functions of the 
macromolecule, using methacrylic anhydride in 
aqueous conditions (Fig. 21A and 21B).99,102,155–158 
The epoxide precursor, i.e. glycidyl methacrylate 
(GMA), is also reported, to react with primary 
amines in the presence of LiBr to yield secondary 
amino groups (Fig. 21C).159 Functionalization has 
been performed on the backbone of proteins such as 
gelatin and silk fibroin,159 oligosaccharides including 
hyaluronic acid,157 and on the extremities of linear or 
branched PEG. A wide range of methacrylated, 
dimethacrylated, and diacrylated (Fig. 22) PEGs of 
various sizes are commercially available. They can be 
prepared from non-functional PEGs, using the same 
types of reaction as those used on biopolymers (e.g. 
methacrylation with methacrylic anhydride in DCM in 
the presence of triethylamine160).  
Introduction of alkenes 
Simpler alkene groups constitute an alternative to 
acrylates, especially for thiol-ene chemistry. They 
are preferentially used for cross-linking between 
two different species. Thiol-ene is a step-growth 
polymerization process, whereas acrylate 
polymerization is a chain polymerization, meaning 
that one may expect to exert better control of the 
cross-linking between different species, and of the 
number of network precursors involved in the 
chain. The polymerization reaction can happen with 
either a thiolated biopolymer or a thiolated bi-
functional linker like dithiothreitol (DTT). 
Allyl groups were introduced by reaction of allyl 
glycidyl ether with primary amines. This has been 
achieved with gelatin in basic medium at 65 °C for 
24h (Fig. 21D).161 Alternatively, amino norbornenes 
may react with carboxylic groups of biopolymers 
activated by carbodiimide (Fig 21E). This has been 
performed on the backbone of alginate.106 
Introduction of thiols 
Thiols are attractive functional groups for cross-
linking bioinks. As already stated, they are partners 
of thiol-ene reactions and Michael addition, but can 
form by oxidation, intermolecular disulfide bridges 
between network precursors.  
Sulfhydryl groups have been introduced through bi-
functional symmetrical disulfides. They first yield 
intra- or inter-molecular bridged species, which are 
further converted into sulfhydryl modified 
polymers by reduction. As an example, the 
hydrazine function of 3,3'-
disulfanediyldi(propanehydrazide) has been 
substituted in the carboxylic acid functions of HA 
activated by carbodiimide (Fig 21F). After reduction 
of disulphide bonds with DTT, a sulfhydryl-
containing HA cross-linkable by oxidation was 
obtained.97 
Introduction of other types of functional groups 
Bio-orthogonal reactions are required to avoid 
unwanted reactions of the network precursors with 
other biomolecules present in the buffer (e.g. 
growth factors, nutriments) or with the proteins on 
the surface of the cells. Such reactions necessitate 
functional groups, which are not naturally present 
in biomolecules such as vinyl moieties. Aldehydes 
and hydrazides may react together through 
hydrazine ligation, which has been used for HA 
cross-linking. Adipic acid dihydrazide was coupled 
to HA to install a hydrazide function on the 
backbone. It is important to note that this 
functionalization should proceed carefully to avoid 
unwanted premature formation of already cross-
linked or cyclic species (Fig. 21G).162 Aldehyde 
functionalized HA has been prepared by controlled 
oxidation of cyclic saccharides of the backbone with 
sodium periodate (Fig. 21H).162 
Fig. 21 Chemical modifications of biomacromolecular 
network precursors: (A) gelatin methacrylation; (B) 
HA methacrylation; (C) silk fibroin methacrylation; 
(D) gelatin allylation; (E) alginate functionalization
with norbornene; (F) HA thiol functionalization; (G)
HA hydrazide functionalization; (H) HA aldehyde
functionalization.
Fig. 22 Functionalized PEGs: (A) polyethylene glycol 
methacrylate; (B) polyethylene glycol 
dimethacrylate; (C) polyethylene glycol diacrylate 
(PEG-MA, PEG-DMA and PEG-DA, respectively). 
Chemical cross-linking reactions used for bioink 
preparation can be sorted between UV-promoted 
reactions (chain growth polymerization of acrylates 
with photo-initiator and radical thiol-ene cross-
linking), bio-orthogonal chemical reactions (Michael 
addition, hydrazide ligation and Schiff base reaction) 
and enzymatic cross-linking. 
4.2.2. Photo cross-linking 
Cross-linking and polymerization can be initiated by 
UV irradiation thanks to the presence of a photo-
initiator in the bioink. Of course, UV irradiation is the 
fundamental principle of stereolithography printers, 
but most 3D extrusion and inkjet 3D bio-printers 
include UV cross-linking devices. The availability of 
such devices has made this mode of polymerization 
very popular. Moreover, photo-catalysed gelation of 
bioinks is very fast (a few seconds), and the liquid 
bioink containing cells can be gelated right after the 
exit of the print head (extrusion nozzle or inkjet). 
Alternatively, UV irradiation can take place on top of 
the printed scaffold. This second option is only 
possible when bioinks are viscous enough not to flow 
immediately after extrusion. 
Perhaps the main drawback of photo cross-linking 
comes from the toxicity of photo-initiators (PI). Only 
a small number of them can be used at low and 
controlled concentrations in water (see 4.2.2.3.). In 
some cases, the toxicity has been reduced by 
washing the scaffold after printing. To perform 
polymerization, different strategies are envisaged. 
For stereolithography and digital light processing, the 
photo-initiator is suspended in the bioink. 
Reticulation takes place where the light beam hits the 
solution, and the shape of the scaffold is made by 
superposition of layers. 
For other bioprinting technologies, the photo-
initiator is solubilized in the bioink or a sacrificial ink, 
and UV curing is performed either during or after 
printing. 
The two main mechanisms of photo cross-linking are 
chain growth photo polymerization and step growth 
polymerization, using two partners, an alkene and a 
thiol. 
 
 Chain growth polymerization 
of acrylated polymer-based 
bioinks 
Chain growth photo polymerization is performed by 
radical polymerization on the kinetic chain (chain in 
expansion during the polymerization). It has been 
used on acrylates and methacrylates, and requires 
only one type of functional group. This means that 
a single type of acrylated precursor can be used as 
a bioink. Alternatively, any other component can be 
part of the cross-linked network insofar as it is 
acrylated (Fig. 23A). This interesting feature means 
that a wide range of hydrogels with various physical 
specificities (viscosity, elasticity, pore size, etc.) can 
be obtained by varying the nature of the precursors 
(e.g. gelatin and PEG), and the ratio of each species 
(e.g. 1/1, 1/10, etc.). 
 
 
Fig. 23 Photo cross-linking reactions used in bioinks: (A) Chain growth polymerization between acrylated 
and methacrylated species; (B) step growth polymerization (radical thiol-ene reaction); (C) Michael addition 
(thiol-acrylate reaction); (D) hydrazide ligation (aldehyde-hydrazide reaction). 
 
  
The most common acrylated network precursor is 
the commercially available methacrylated gelatin 
(Gel-MA, Fig. 21A). 20% to 95% of gelatin repetition 
units can be modified by acrylate, depending on the 
amount of equivalents of reagents used to 
functionalize gelatin. It has been printed by nanoliter 
droplet deposition55 at about 5 % w/v concentration, 
and printed by stereolithography or DLP, using a vat 
at 10 to 30 % w/v concentration.163 With a 10 % w/v 
concentration, it can be extruded.92 The gelation 
time depends on the PI used and its concentration 
(from less than one minute to a few minutes). 
As explained above, Gel-MA can be used either alone 
for extrusion or in association with other modified 
macromolecules such as methacrylated-hyaluronic 
acid (HA-MA, Fig. 21B).157 Di Bella et al.164 also used a 
2:1 Gel-MA/HA-MA mixture as an ink to load a 
custom-made extrusion bio-pen. One cartridge was 
filled with the ink and another with the cell 
embedded ink, both delivered at the same time. They 
used this pen to directly fill a defect present on a 
sheep knee.  
It is also possible to add non methacrylated 
compounds like silk fibroin155 to print by digital light 
processing, or gellan gum embedding PLA-micro 
carriers containing cells for extrusion.165 Chimene et 
al.102 developed a multicomponent bioink (called 
NICE, or Nano-engineered Ionic-Covalent 
Entanglement) composed of Gel-MA, κ-carrageenan 
and 2D-nanosilicates. By extrusion and UV cross-
linking, they obtained constructs with high fidelity, 
stiffness and elasticity. Yin et al.156 extruded a Gel-
MA and gelatin bioink. The specificity of this bioink 
resides on a two-step cross-linking protocol 
consisting of fast and reversible thermo cross-linking 
of gelatin, and irreversible photo cross-linking of Gel-
MA. It allowed better printing accuracy and fidelity 
with good cell viability, than using them alone.  
Liu et al.166 used a co-axial extrusion process to 
simultaneously print a Gel-MA solution containing 
cells and CaCl2, and alginate sheath. Both ionotropic 
gelation and UV cross-linking occurred, yielding 
micro-fibers. Zhu et al.99 also used co-axial extrusion 
of a core bioink made out of Gel-MA, alginate and 
gold nanorods coated with Gel-MA, and a calcium 
chloride shell solution. These gold nanorods allowed 
them to improve the conductivity of the scaffold, and 
to reach an efficient electrical coupling between 
adjacent cardiac cells, inducing better spreading and 
organisation, to perform cardiac repair. The 
extrusion of a Gel-MA shelf has also been commonly 
used with sacrificial pluronic core with PDMS98 or 
alginate, and 4 arms PEG-tetra-acrylate (PEGTA)167 
mixed with the Gel-MA. However, after UV-curing, it 
has been possible to use an EDTA vat, which 
complexes calcium ions, to remove the liquefied 
alginate leaving to a vascularized construct. 
 
PEG derivatives are also a common class of UV cross-
linkable precursors. Bi-functional PEGs (e.g. PEG-
DMA, PEG-DA, Fig. 22) have been used for inkjet 
printing.168,56  
 
Composite bioinks can be prepared by also mixing 
non-acrylated components, molecules and particles. 
Peak et al.169 mixed disk-shaped 2D nanosilicates and 
PEG-DA to obtain a colloidal bioink that could be UV 
cross-linked, with self-healing properties. Gao et 
al.101 inkjet-printed a bioink made out of PEG-DMA, 
hydroxyapatite and nanoparticles of bioactive glass 
(BG 45S5). These two different osteogenic factors 
improved cell differentiation in osteoblasts, resulting 
in a scaffold with a higher compressive modulus, 
which is essential for bone tissue engineering. 
 
As for Gel-MA based bioinks, other acrylated 
compounds can be covalently incorporated in the 
network to afford additional properties. Xu et al.170 
used a triblock copolymer of diacrylated PCL-PEG-PCL 
as a major component of their extruded bioink (Fig. 
24) that reacts as other diacrylated compounds (Fig 
18A). It can also be used to introduce RGD sequences 
(using RGD-PEG-DA monomer), which enhance 
cellular adhesion.59 There is no limitation in the 
number of different acrylated components that can 
be combined in the bioink. For example, an enzyme-
degradable bioink, printed by inkjet, was prepared by 
mixing PEG-DMA, acrylated RGD sequences and 
acrylated MMP-sensitive peptide sequences (e.g. 
GCRDGPQGIWGQDRCG).57,58 
 
 
Fig. 24 A) PEG-PCL-DA bioink,170 and (B) acrylated-
RGD.57,58 
 
Combination of PEG and gelatin, two of the most 
popular acrylated precursors, has been investigated 
for stereolithography171 or extrusion.172 
 
The only other reported example of acrylated 
network precursors as bioink components, besides 
gelatin and PEG, is methacrylated silk fibroin (Fig. 
21C), which was successfully used as a light 
processing 3D printable bioink precursor.159 
 
 Thiol-ene radical photo-
polymerization-based bioinks 
From a mechanistic point of view, the thiol-ene 
radical polymerisation reaction is very different from 
the chain growth polymerization. Indeed, it requires 
two distinct partners: a nucleophile acceptor 
(alkene), and a thiyl radical obtained by activation of 
a thiol using a PI under UV irradiation (Fig. 23B). 
Strictly speaking, the network is established by 
repetition of multiple cross-linking and not by the 
polymerization of the same monomer.  
This process has been described by reaction between 
allylated gelatin (GelAGE, Fig. 21D) and DTT 
(Dithiothreitol) as cross-linker, for extrusion and 
stereolithography.161 With this same reaction, 
norbornene functionalized alginate (Fig. 21E) can be 
cross-linked with PEG-dithiol.106 Thiol functionalized 
RGD sequences were also added to improve bioink 
cell adhesion. Stichler et al.97 developed a bioink 
with thiol-HA (Fig. 21F) and poly(allyl glycidyl ether-
co-glycidyl) (P(AGE-co-G). They successfully extruded 
this bioink in alternation with PCL layers. 
 
 UV photo-initiators 
A limited number of photo-initiators (PI) have been 
used for bioprinting (Fig. 25). This can be explained 
by the cytotoxicity and the poor water solubility of 
most of them. PIs are mostly used at concentrations 
ranging from 1.7 to 0.01 mM depending on their 
respective toxicity. The most used is Irgacure 2959 
(I2959),10,55,57–59,92,97,98,161,162,165,168 ([4-(2-
hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-
propane-1-one, Fig. 25A), which absorbs at 257 nm. 
Lithium phenyl(2,4,6-trimethylbenzoyl)phosphinate 
(LAP, Fig. 25B) absorbs at 375 nm and is less toxic 
than Irgacure.106,159,170 Eosin Y (2′,4′,5′,7′-
tetrabromofluorescein disodium salt, Fig. 25C) 
absorbs at 514nm (blue visible light), which induces 
less oxidative stress for cells.155,171 It is worth noting 
that only eosin Y and I2959 have been FDA-approved 
to date. 
 
 
Fig. 25 Common photo-initiators used in 3D 
bioprinting: A) Irgacure 2959; B) LAP; C) Eosin Y. 
 
4.2.3. Chemical cross-linking 
Needless to say, some well-known bioconjugation 
‘click’ reactions have been used for bioink 
reticulation. Indeed, they take place in water, in a 
highly efficient and in ideal conditions in a bio-
orthogonal manner. Unlike acrylate polymerization, 
such reactions proceed between two different types 
of mutually reactive groups (e.g. aldehyde and 
hydrazide, maleimide and thiol). This implies that a 
mixture of two (or more) different precursors, each 
one bearing a different reactive moiety, must be used 
to form the network. The combination potential gives 
considerable freedom in the design of hydrogels with 
different physical properties, depending on both the 
ratio of each monomer and on the amount of cross-
linking. Surprisingly, despite its immense popularity, 
Huisgen 1-3 dipolar cycloaddition has not been 
exploited in bioprinting so far, probably due to the 
toxicity of the copper catalyst. Even its metal-free 
counterpart, strain promoted alkyne-azide 
cycloaddition (SPAAC), has not been used until now 
for bioink preparation. This is not the case for thiol-
based ligation methods. Strictly speaking, thiol-
based conjugation is not bio-orthogonal as proteins 
present in the bioink (i.e. on the cell surface or as 
soluble factors) contain cysteine residues, which 
could react with sulfhydryl containing compounds, 
even when most cysteines are involved in disulfide 
bridges in proteins. However, this chemistry is still 
extensively used in bioinks, either with simple vinyl 
groups or with acrylates, which are easier to 
prepare.173–176 Non-radical thiol-ene chemistry (i.e. 
Michael addition) generates no side products and is 
highly selective. The addition can be nucleophile-
catalysed, but in bioinks the medium cannot be too 
basic, pH should be kept close to neutrality. However, 
it is important to realise that the reaction takes a few 
minutes to start, and if the viscosity is not sufficient, 
the bioink needs to be cross-linked enough before to 
be printed or mixed with a stiffer component. 
Skardal et al.177 developed a Michael addition-based 
bioink including two network precursors: a thiolated 
HA (synthesised as previously described Fig. 22F) and 
a 4-arms PEG bearing an acrylate moiety at each of 
its extremities (named TetraPAc8 or TetraPAc13 
depending on the size of the PEG, Fig. 26). Notably, 
the resulting chemical cross-linked hydrogel was also 
stabilised by non-covalent interactions between 
hyaluronic acid chains. This bioink was printed by 
micro-extrusion, after 30 minutes of cross-linking, 
using micro capillary tubes instead of regular 
syringes. Using agarose hydrogel as a sacrificial ink, 
cellularized vessel-like constructs were prepared. 
Classical maleimide-thiol Michael addition has also 
been exploited to create bioinks. Yan et al.178 used 
thiolated gelatin soaked for 15 minutes in a solution 
containing bi-functional maleimide PEG, to yield a 
network cross-linked through thioether bonds. 
Notably, amphiphilic fibril-forming peptides (acetyl-
VVAAEEIKVAV and acetyl-VVAAEE) derived from 
laminin sequences have been also added in the 
bioink to facilitate a non-covalent gelation at 4 °C and 
improve the cell adhesion. The initial physical 
network was strengthened by chemical cross-linking 
at 37 °C, and induced a higher cell viability because of 
the peptides.  
Aldehyde-hydrazide ligation yields hydrazone 
linkage in a fully chemoselective manner. This 
reaction proceeds by addition of the hydrazide on 
the aldehyde with water formation (Fig. 23D). For 
example, HA-based two-component bioinks have 
been 3D-printed by extrusion, after 2 hours of 
cross-linking. Hydrazone linkages were formed 
between HA modified with hydrazide groups and 
HA displaying aldehyde functions (Fig. 21 G and 
H).162 
  
 
 
Fig. 26 Bioink formation between thiol-HA and TetraPAc.177 
 
The aldehyde function may also react with amino 
groups to form an imine via a Schiff-base reaction 
(Fig. 23D), by the same mechanism than hydrazine 
ligation, typically under basic conditions. This 
reaction is reversible by acidification, however the pH 
of transition depends on the stability of the resulting 
imine-containing compound. This mean that for 
some compounds the reaction can be done at 
physiological pH. Du et al.179 extruded a mixture of an 
oxidized dextran functionalized with aldehyde 
moieties and gelatin. The aldehyde moieties reacted 
with amino groups of gelatin yielding imines at 
physiological pH (from 6 to 8) (Fig. 27). It should be 
stressed that gelatin itself forms a physical hydrogel 
and helps to the stability of the printed scaffold. In 
addition of its pH sensitivity, the mixture is also 
thermo sensitive thanks to gelatin. At pH 7.4 and 37 
°C, gelation happens within 20 minutes, but occurs in 
only 5 minutes at 18 °C. Indeed, the low temperature 
induces a phase separation, which corresponds to 
the colloidal form of gelatin. 
 
 
Fig. 27 Bioink formation between oxidized dextran 
and gelatin.179 
 
4.2.4. Enzyme-driven gelation 
Enzymes are attractive auxiliaries to perform 
chemical cross-linking in cell-friendly conditions, 
with a bio-orthogonal control of the gelation 
process, and high specificity. They can be used 
either to generate a new reactive functional group 
on a network precursor (e.g. aldehyde) that may 
subsequently react with another mutually reactive 
moiety, or to directly cross-link the components of 
the bioink (e.g. forming amide bonds). However, 
the use of enzymes excludes excessive harsh 
conditions (high temperature, solvents or 
denaturing compounds), which are less permissive 
than for cell embedding. A few studies have been 
published on enzymatic gelating bioinks to date. 
Indeed, this is not a straightforward task, as specific 
substrate sequences recognized by enzymes must 
be introduced within the precursors. Enzymes are 
also expensive materials and their production, from 
animal extracts and recombinant bacterial origin, is 
not easily compatible with human body 
implantation. These issues may constitute a barrier 
to the widespread use of enzymatic cross-linking for 
3D printing.  
 Transglutaminase gelation 
Transglutaminase catalyses transamidification 
between lysine and glutamine side chains (Fig. 28), 
yielding an inter chain amide bond. Dai et al.180 used 
this transglutaminase (1 wt%) to generate covalent 
cross-linking between gelatin macromolecules. In a 
similar fashion to other chemical bioinks able to 
cross-link, a physical hydrogel precursor such as 
alginate that has been incubated in a CaCl2 vat, was 
used as an additional component of the bioink to 
facilitate the extrusion process, and to maintain the 
integrity of the printed scaffold, while enzymatic 
cross-linking reaction proceeded.  
Fig. 28 Transglutaminase cross-linking. 
Enzymatic activation of 
gelation 
In a different strategy, enzymes can be used to 
generate reactive groups on the backbone of 
network precursors (e.g. biopolymers or synthetic 
polymers), which may afterwards react with other 
moieties, like in chemical cross-linking (see 4.2.3). 
Arai et al.181 exploited the reactivity of the phenoxy 
radical generated from phenols by horseradish 
peroxidase (HRP, Fig. 29). These radicals react with 
each other to form oxydibenzene. These reactions 
allowed gelatin and phenolic-modified alginates 
polymerization. The second one was synthesised 
according to the same process than norbornene-
functionalized alginates, but with tyramines as 
second reactants (Fig. 21E). Once again, alginate 
CaCl2-induced ionotropic gelation contributed to the 
stability of the inkjet-printed scaffold during the 
enzymatic reaction. 
Monoamine oxidase B (MOA-B) specifically 
transforms benzylamine into benzaldehyde through 
a benziminium intermediate. Consequently, Wei et 
al.182 have used MOA-B to turn bifunctional PEG 
terminated by 4-aminomethyl benzoic acid into its di-
benzaldehyde counterpart, which reacted as a 
bifunctional cross-linker with primary amines of 
glycol chitosan or gelatin yielding Schiff base linkages 
(Fig. 30). Unfortunately, the MOA-B-catalysed 
reaction generates hydrogen peroxide, which is toxic 
for cells. Catalase was added to convert H2O2 into 
water and dioxygen, thus improving cell viability. 
Fig. 29 Enzymatic oxidation with HRP.181 
Fig. 30 Mechanism of bioink gelation using MOA-B 
and Schiff base cross-linkers.182 
Thrombin/Fibrinogen bioink 
The last example of enzyme-based gelation of bioinks 
was directly inspired by the clotting of fibrinogen by 
thrombin, leading to fibrin fibers (Fig. 31).67 
Fibrinogen is a hexameric glycoprotein, which is 
cleaved by thrombin at the N-terminus part of its 
alpha and beta chains (giving fibrinopeptides side 
products) lead to self-assembly between its D and E 
domains, turning it into fibrin fibers by 
polymerization. 
Cui and Boland183 proceeded by direct biomimicry 
using a solution of thrombin (50 unit/ml) with cells. 
This bioink was inkjet-printed on a support (i.e. bio-
paper) constituted of fibrinogen. The clotting 
reaction occurred at the interface of the bio-paper 
and the bioink. They used a low viscosity solution 
containing the enzyme and cells thus limiting this 
strategy to inkjet printing of thin constructs. 
Accordingly, Xu et al.94 combined 
fibrinogen/thrombin with collagen to print 
cellularized layers alternated with layers of PCL-
pluronic by inkjet printing. Zhang et al.82 used two 
bioinks with the same composition (composed of 
fibrinogen, gelatin and hyaluronic acid), with two 
different types of cells. These bioinks were viscous 
enough to be extruded with polylactic-co-
caprolactone (PCL-PLCL) layers to perform a co-
culture, after incubation in a thrombin solution vat, 
to cross-link bioinks.  
 
 
Fig. 31 Thrombin-driven fibrinogen polymerization 
(adapted from Biochemistry 7th Edition, 2012, W. H. 
Freeman and Co.). 
 
Fibrinogen and thrombin have been printed in 
different bioinks, meaning that the enzyme will 
migrate through it or the printed scaffold is placed in 
a vat  containing the enzyme, as a post-printing 
process.  
Skardal et al.117 printed a bioink made out of 
fibrinogen, collagen and cells, in alternation with 
layers of a thrombin solution, directly into a wound 
on the back of mice, by inkjet process. Kolesky et al.91 
co-extruded a cell-embedded fibrinogen-gelatin 
bioink with a core of pluronic-thrombin sacrificial ink. 
The enzyme diffused from the core to the outer 
layers containing the fibrin, yielding artificial vessels 
after removal of the Pluronic. 
 
5. Conclusion and prospects 
Access to 3D-bioprinting for laboratories has never 
been so easy, thanks to a range of affordable 3D 
printers, which all claim cell-handling compatibility.  
The 3D bioprinting popularity is growing along with 
the well-documented utilization of a handful of 
robust, commercially available, ‘basic’ hydrogels 
including gelatin, HA, alginate, which may embed 
cells during the printing process.  
Physical hydrogels based on biopolymer network, 
used as single components and as mixtures, 
dominate the field. Their use for bioprinting does not 
require any chemistry. However, when long-term 
applications or more demanding mechanical 
properties are targeted, the development of 
chemical hydrogels is necessary. Even in this case, the 
use of physical hydrogels as additional components is 
appreciated to alleviate the lack of stiffness after the 
printing process, and to keep the integrity of the 
scaffold while the chemical reaction proceeds.  
The majority of the chemical bioinks used are photo-
polymerized, owing to the compatibility this process 
offers, with many printers, many network precursors 
and cells. 
A relatively small repertory of cross-linking reactions 
including thiol-ene and acrylate polymerization, is 
used. For the organic chemist, there is a lot of scope 
for imagination or simply for applying efficient bio-
orthogonal ligation procedures to the field of 
bioprinting.  
Whatever the application chosen, from vascularized 
tissues, organs and scaffolds for tissue engineering, 
to disease models and chips for high-throughput 
screening, the trend is towards increasing complexity 
of the printed construct. Indeed, the ultimate goal is 
to reproduce the hierarchical micrometric 
organization of tissues as well as their diverse 
mechanical properties. The challenge is taken up via 
two approaches including (i) combination of several 
printing techniques to sequentially construct bulk 
material and small, highly organised structures like 
vessels, with higher resolution, and (ii) addition in the 
scaffold of different materials such as plastic 
supporting layers, sacrificial ink, and embedded 
fibers or nanoparticles in the bulk, yielding composite 
bioinks matching the targeted properties. The other 
scientific challenge is the creation of biologically 
active scaffolds that not only pass the test of 3D 
printing and guarantee the survival of printed cells, 
but also enable cells to grow, differentiate, migrate 
and be organized into relevant biological structures. 
A lot of effort has been devoted to this field, 
essentially by adding bioactive compounds including 
signalling peptides, growth factors, drugs whose 
release and availability in the hydrogel could be 
triggered by various release systems (e.g. porous 
particles, micelles, sensitive linkers). Covalent 
modifications of the hydrogel network find here all 
their significance, either giving permanent cell-
binding properties to the network or enabling the 
controlled and sustained release of a drug via a 
system that can be targeted. For tissue-engineering 
applications, enzyme-sensitive degradation 
sequences can be inserted into the covalent hydrogel 
matrix to enhance the degradation of the artificial 
scaffold and its replacement with the newly 
synthesized ECM. Once again, bio conjugation 
chemistry is here, one of the major players.  
Bioprinting is still in its infancy, and the first phase has 
been mostly occupied by printer’s technological 
optimization, and development of bioink 
formulations suitable for each printing technique 
using combinations of well-known polymers and 
cross-linking chemistries. The next frontier that must 
be crossed is the development of universal, 
multifunctional and tunable bioinks that can be 
mixed together to enable a full range of biological 
and mechanical properties of tissues to be mimicked, 
from bone to brain and vessels. The density of cross-
linkers and the length and geometry of network 
precursors define the resulting physical 
characteristics of the material. When an in-human 3D 
printed tissues is envisioned, one must move away 
from using animal extracts as bioinks. Synthetic 
biomolecules including proteins and oligosaccharides 
should be preferred to afford closer analogues of 
natural tissues. These synthetic biomimetic 
components should allow chemical cross-linking 
and/or present self-assembling properties to 
generate a suitable hydrogel network, while keeping 
their bioactivity. Finally, the universality of the 
system, i.e. the same type of chemistry for assembly 
applied to all the different network precursors and 
additional components, will alleviate the problem of 
integration between layers, and simplify the overall 
conception of a multi scale non-homogeneous 
scaffold printed with different 3D bio-printers. 
Table 2  Physical bioinks described in the literature (NA = not assayed, NS = not specified) 
GELATION 
PROCESS 
NETWORK 
PRECURSOR  
NETWORK 
PRECURSOR 
CONCENTRATION 
OTHER 
COMPONENTS 
POST 
PRINTING 
PROCESSING 
PRINTER TYPE CELL TYPE CELLULAR 
CONCENTRATION 
CELLULAR 
VIABILITY 
IN VIVO 
ASSAYS 
APPLICATION REF. 
aggregation agarose (type VII) 2% extrusion bone marrow 
derived 
mesenchymal 
stem cells 
(BM-MSCs) 
20*106 cells/ml 90% after 
printing 
cartilage tissue 
engineering 
92
aggregation agarose (ultra-low-
gelling-
temperature) 
1.3-1.5% w/v Fmoc-dipeptide 
solution (1mM) + 
collagen (15 µg/ml) 
printing into 
an oil vat 
droplet-based 
(piezoelectric 
generator) 
HEK-293T cells 
and ovine 
mesenchymal 
stem cells (MSCs) 
5-15*106 cells/ml  90% after 
printing 
platform 124
aggregation hyaluronic acid + 
methylcellulose 
2.0 wt% and 5-9 
wt% 
extrusion sheep MSCs NS >75% after 
printing 
platform 184
ionotropic catechol-
conjugated-
chitosan  
2 wt% vanadyl ion solution 
(50µM) 
printing into 
media with 
serum (FBS, 
5-25%) 
extrusion L929 cells 10*106 cells/ml 90% after 
printing 
platform 153
ionotropic endotoxin-free 
low-acyl gellan 
gum 
1% w/v droplet 
ejection + 
inkjet 
mouse C2C12 
cells and PC12 
cells 
0.2-2*106 cells/ml 
and 1-6*106 
cells/ml 
95% after 
printing 
platform 152
ionotropic e + sodium 
alginate 
6 and 5 wt% incubation in 
CaCl2 solution 
after printing 
extrusion porcine aortic 
valve interstitial 
cells (AVIC) or 
Human aortic 
root smooth 
muscle cells 
(SMC) 
10*106 cells/ml  >85% after 
printing 
aortic valve 
conduit 
construction 
139
ionotropic gelatin+ sodium 
alginate 
12% and 2.4% w/v incubation in 
CaCl2 solution 
after printing 
extrusion mouse epidermal 
stem cells (ESCs) 
1*106 cells/ml  >90% after 
printing 
platform 140
ionotropic Gellan gum-RGD 
(core) 
0.5% w/v CaCl2 solution (shelf) co-axial 
extrusion 
primary mouse 
cortical neurons 
1*106 cells/ml  >70% after 
2h 
representation 
of 3D brain-like 
structure 
105
ionotropic nanofibrilated 
cellulose + sodium 
alginate 
1.5-2 % w/v and 1-
0.5% w/v 
mannitol (4.6%) incubation in 
CaCl2 solution 
after printing 
extrusion human induced 
pluripotent stem 
cells (hIPSCs) 
20*106 cells/ml  good (non 
quantitative) 
cartilage repair 141
ionotropic nanofibrillated 
cellulose / sodium 
alginate (NFC-A) 
bioink 
(from CELLINK AB) 
92% v/v from 
commercial 
concentration 
incubation in 
CaCl2 solution 
after printing 
extrusion hBMSCs)and 
human nasal 
chondrocytes 
(hNCs) 
10*106 cells/ml  NA female 
Balb/c 
nude mice 
cartilage repair 142
ionotropic sodium alginate 3.5% CaCl2 incubation in 
CaCl2 solution 
after printing 
extrusion BM-MSCs 20*106 cells/ml 80%  after 
printing 
cartilage tissue 
engineering 
92
ionotropic sodium alginate 8wt% collagen or agarose 
(0.3 wt%) 
incubation in 
CaCl2 solution 
after printing 
extrusion rat primary 
chondrocytes 
10*106 cells/ml >80% after 
printing 
cartilage tissue 
engineering 
144
ionotropic sodium alginate 2-1% w/v insoluble dentin 
proteins or soluble 
dentin molecules  
extrusion mouse 
odontoblast-like 
cells (OD21) and 
stem cells from 
the apical papilla 
(SCAP) 
2*106 cells/ml and 
0.6*106 cells/ml  
>70% after 1 
day 
regenerative 
dentistry 
147
ionotropic sodium alginate 3% w/v laponite (3% w/v) + 
methylcellulose (3% 
w/v) 
incubation in 
CaCl2 solution 
after printing 
extrusion hMSCs 
expressing hTERT 
(human 
telomerase 
reverse 
transcriptase) 
0.5*106 cells/ml 70% after 1 
day 
bone tissue 
engineering 
143
ionotropic sodium alginate 2.5% 2.5% hydroxyapatite 
+ 1% polyvinyl 
alcohol (PVA) + 
0.15% Na2HPO4 +, 
0.20% CaSO4 
extrusion mouse calvaria 
3T3-E1 
(MC3T3) cells 
0.01*106 cells/ml 80% after 
printing 
bone tissue 
engineering 
61
ionotropic sodium alginate 2.5% 2.5% hydroxyapatite 
+ 1% polyvinyl 
alcohol (PVA) + 
0.15% Na2HPO4 +, 
0.20% CaSO4 
incubation in 
CaCl2 solution 
extrusion MC3T3 cells 1*106 cells/ml >90% after 1 
day 
bone tissue 
engineering 
62
ionotropic sodium alginate 3wt% cell-freezer solution 
(Gen-1001)  
CaCl2 
incubation in 
CaCl2 solution 
after printing 
extrusion (low-
temperature 
processing 
method 
(DLTM)) 
osteoblast-like 
cells MG63, 
CRL-1427 and 
hMSCs 
1*106 cells/ml 70-80% after 
printing 
platform 145
ionotropic sodium alginate 1wt% printing into 
CaCl2 solution 
inkjet NIH 3T3 mouse 
fibroblasts 
5*106 cells/ml 90% after 
printing 
vascularized 
tissue 
engineering 
138
ionotropic sodium alginate 0.8-1% printing into 
CaCl2 solution 
inkjet (self 
developed) 
HeLa cells 6*106 cells/ml NA platform 137
ionotropic sodium alginate 2wt% EDTA human blood 
plasma 
incubation in 
CaCl2 solution 
after printing 
laser-induced 
forward 
transfer 
mouse NIH-3T3 
Swiss albin + 
human 
immortalised 
keratinocyte cell 
line, HaCaT 
33*106 cells/ml NA skin tissue 
generation 
8
ionotropic sodium alginate 1% w/v nano-hydroxyapatite 
+ glycerol (10% v/v) 
laser-induced 
forward 
transfer 
EA.hy926 
endothelial cell 
30-50*106 cells/ml good (non 
quantitative) 
platform 63
ionotropic sodium alginate 
(core) 
3% w/v CaCl2 solution (shelf) co-axial 
extrusion 
rat myocardial 
cell 
lines (H9C2) 
1*106 cells/ml >90% after 
printing 
platform 150
ionotropic sodium alginate 
(shelf) 
3-5% w/v CaCl2 solution (core) coaxial 
extrusion (self 
developed) 
primary human 
umbilical vein 
smooth muscle 
cells 
(HUVSMCs) 
10*106 cells/ml 35% after 
24h 
vascularized 
tissue 
engineering 
149
ionotropic sodium alginate of 
different sizes 
1-5 wt% printing into 
CaCl2 solution 
extrusion NIH 3T3 
fibroblast 
3.5*106 cells/ml good (non 
quantitative) 
platform 136
self-
assembly 
collagen (from rat) 0.2wt% NaOH 
(neutralization) 
droplet 
ejection 
rat smooth 
muscle cells 
0.1-1*106 cells/ml 94% after 
printing 
platform 119
self-
assembly 
collagen (from rat) 1.25-1.75 wt% NaOH 
(neutralization) 
extrusion bovine 
fibrochondrocyte
s 
10*106 cells/ml >90% after 
printing 
cartilage repair 120
self-
assembly 
collagen (from rat) 86% v/v (no 
information of 
original 
concentration) 
NaOH 
(neutralization) 
laser-assisted 
bioprinting 
NIH3T3 
fibroblasts  and 
HaCaT 
keratinocytes 
35*106 cells/ml NA male 
Balb/c 
nude mice 
skin tissue 
regeneration 
46
self-
assembly 
collagen type I 
(from rat tail ) 
0.24% w/v polyvinylpyrrolidone 
(PVP, 0-11.3% w/v) 
 +  NaOH 
(neutralization) 
microvalve-
based printer 
normal human 
dermal 
fibroblasts (hDFs) 
0.15*106 cells/ml  good (non 
quantitative) 
platform 104
self-
assembly 
dECM 1.5-2.5% extrusion NIH3T3 cells NS 95% after 1 
day 
platform 76
self-
assembly 
guanosine + 
boronic acid + 
potassium 
hydroxide (G 
quadruplex 
formation) 
50 mM, 50 mM 
and 25 mM 
extrusion adult hDFs NS 98% after 1 
day 
platform 133
self-
assembly 
heart tissue-
derived 
decellularized 
extracellular 
matrix (hdECM) 
2% w/v vitamin B2 (0.02% 
w/v) + vascular 
endothelial growth 
factor (VEGF, 
10µg/ml) 
extrusion human cardiac 
progenitor cells 
(hCPCs) + hMSC 
5*106 cells/ml  90% after 
printing 
Balb/c 
nude mice 
stem cell 
patch( cardiac 
repair) / 
platform 
52
self-
assembly 
Hydroxypropyl 
chitin + matrigel 
2-3% w/v and 0-
30% v/v 
extrusion (hiPSCs 1*106 cells/ml  >85% after 
3D printing 
platform 118
self-
assembly 
peptides from 
PeptiGelDesign 
original 
commercial 
concentration 
extrusion EpH4 (mammary 
epithelial cells) 
4*106 cells/ml  good (non 
quantitative) 
platform 132
self-
assembly 
self-assembling 
lysine-containing 
ultrashort Peptides 
0.5% w/v extrusion hMSC and Caco2 
cells 
NS good (non 
quantitative) 
C57BL/6 
mice 
three- 
dimensional 
organotypic 
cultures 
185
self-
assembly 
silk fibroin 3.75-10% w/v PEG 400 (40% w/w) extrusion hMSC and Mouse 
NIH/3T3 
cells 
2*106 cells/ml  good (non 
quantitative) 
Danforth’s 
short tail 
(SD) 
mice 
platform 122
thermo-
sensitive 
block copolymers 
comprising 
hydrophilic poly(2- 
methyl-2-
oxazoline) and 
thermoresponsive 
poly(2-n-propyl-2- 
oxazine) (nPrOzi) 
20 wt% extrusion Murine NIH 3T3 
fibroblasts 
1*106 cells/ml 85% after 1 
day 
platform 126
thermo-
sensitive 
PU (polyurethane) 
nanoparticles (PCL 
et PLA) 
25-30% extrusion murine neural 
stem cells 
4*106 cells/ml 40-80% after 
24h 
zebra fish central nervous 
system repair 
127
Table 3  Chemical bioinks described in the literature (NA = not assayed, NS = not specified) 
GELATION 
PROCESS 
NETWORK 
PRECURSOR  
NETWORK 
PRECURSOR 
CONCENTRATION 
OTHER 
COMPONENTS 
POST PRINTING 
PROCESSING 
PRINTER TYPE CELL TYPE CELLULAR 
CONCENTRATION 
CELLULAR 
VIABILITY 
IN 
VIVO 
ASSAYS 
APPLICATION REF. 
ENZYMATIC 
CATALYSE 
OXIDATION 
phenolic 
hydroxyl (Ph) - 
alginate + 
gelatin-Ph 
1.5% and 0.5% horseradish 
peroxidase (HRP, 
50 U/ml) 
printing into a H2O2 
and CaCl2 vat 
inkjet (self 
developed) 
SWISS 3T3-
albino 
fibroblasts 
6*106 cells/ml 90% after 
24h 
platform 181
ENZYMATIC 
CROSS-LINKING 
gelatin +  
sodium 
alginate + 
fibrinogen 
10%, 1%, 1% and 
1% 
transglutaminase 
(1%) 
incubation in CaCl2 
solution and thrombin 
(20U/ml) 
extrusion glioma stem 
cells, SU3 cells 
0.5*106 cells/ml 85% after 
printing 
brain tumour 
model 
180
ENZYMATIC 
POLYMERIZATION 
thrombin 50 unit/ml Ca2+ (80mM) printing into a 
fibrinogen solution 
(60 mg/ml) and 
incubation at 37°C 
after printing 
inkjet hMVEC 1-8*106 cells/ml good (non 
quantitative) 
microvasculature 
fabrication 
183
ENZYMATIC 
REACTION 
(SCHIFF BASE 
LINKAGE) 
PEG-BA 
(benzylamine) 
+ glycol 
chitosan (GC) 
7 wt% and 3 wt% catalase (200U) + 
Monoamine 
oxidase B (MAO 
B, 5 mg/ml) 
extrusion NIH 3T3 cells NS >95% after 
48h 
dynamic 
platform 
182
HYDRAZONE 
CROSS-LINKING 
hyaluronic 
acid hydrazide 
+ HA-
aldehyde 
1.5-5 wt% total 
with equal mass 
ratio 
extrusion 3T3 fibroblasts 2*106 cells/ml >80% after 1 
day 
platform 162
SCHIFF BASE 
REACTION 
gelatin + 
dextran-
aldehyde 
5 wt% and 5 wt% low temperature 
printing (18°C), 18°C 
incubation during 2 
hours then 37°C 
extrusion hDFs  1*106 cells/ml 95% after 
printing 
platform 179
THIOL-ACRYLATE 
REACTION 
thiolated HA 
(CMHA-S) + 
2% w/v + 2% w/v NaOH 
(neutralization) 
extrusion NIH 3T3 cells 25*106 cells/ml good (non 
quantitative) 
synthesis of 
blood vessel-like 
structures 
177
four-arm-PEG 
tetra acrylate 
UV CROSS-
LINKING 
PEG-DA 10% w/v Irgacure 2959 
(0.05% w/v) + 
TGF-β3 (10 
ng/mL)  
UV irradiation after 
printing 
inkjet hMSCs 5*106 cells/ml 90% after 
printing 
cartilage tissue 
engineering 
56
UV CROSS-
LINKING 
acrylated PEG-
PCL triblock 
copolymer 
40% w/v LAP (0.5% w/v) light irradiation extrusion mouse 3T3 
fibroblasts 
5*106 cells/ml 90% after 1 
day 
platform 170
UV CROSS-
LINKING 
alginate-
norbornene 
modified + 
PEG dithiol 
2 wt% and 10% 
mol 
LAP (2mM) printing into cell 
culture medium and 
UV irradiation after 
printing 
extrusion mouse L929 
fibroblast 
3*106 cells/ml >90% after 
printing 
platform 106
UV CROSS-
LINKING 
GelAGE (allyl 
glycidyl ether) 
10-20 wt% DTT + Ru/SPS 
(1/10 × 10−3 M) 
visible-light irradiation 
after printing 
extrusion porcine 
chondrocytes 
3*106 cells/ml good (non 
quantitative) 
platform 161
UV CROSS-
LINKING 
Gel-MA 10% w/v silk fibroin 
particles (0-1% 
w/v) + Eosin Y 
(0.1mM) 
PBS washes digital light 
processing 
NIH 3T3 cells 1.5*106 cells/ml >90% after 
printing 
platform 155
UV CROSS-
LINKING 
Gel-MA 5% Irgacure 2959 
(0.5%) + BMP-2 
(20 ng/mL) or 
TGF-β1 (10 
ng/mL) + NaOH 
(neutralization) 
UV irradiation after 
printing 
nanoliter 
droplets 
deposition 
hMSC 1*106 cells/ml >90% after 
24h 
mimation of the 
native 
fibrocartilage 
phase / platform 
55
UV CROSS-
LINKING 
Gel-MA 10% Irgacure 2959 
(0.05%) 
UV irradiation after 
printing 
extrusion BM-MSCs 10*106 cells/ml 80%  after 
printing 
cartilage tissue 
engineering 
92
UV CROSS-
LINKING 
Gel-MA 15% Eosin Y 
(0.02mM) 
PBS washes stereolithography NIH 3T3 
fibroblasts 
8*106 cells/ml >80% after 1 
day 
platform 163
UV CROSS-
LINKING 
Gel-MA + 
gellan gum 
10% w/v and 1% 
w/v 
PLA micro-
carriers 
functionalized 
with human 
recombinant 
collagen type I 
loaded with cells 
(40mg/ml) + 
Irgacure 2959 
(0.1% w/v) + 
mannose (5.4% 
w/v) 
UV irradiation after 
printing 
extrusion rat MSCs 8*106 cells/ml >70% after 1 
day 
platform 165
UV CROSS-
LINKING 
Gel-MA + 
PEG-DA 
0-7.5% and 10-
2.5% 
Eosin Y 
(0.01mM) 
PBS washes stereolithography NIH 3T3 
fibroblasts 
5*106 cells/ml >80% after 
printing 
platform 171
UV CROSS-
LINKING 
HA-MA + Gel-
MA 
4% w/v and 6-
12% w/v 
Irgacure 2959 
(0.05% w/v) 
UV irradiation after 
printing 
extrusion hAVICs 5*106 cells/ml >90% after 
printing 
bioprinting of 
heart valve 
conduit 
157
UV CROSS-
LINKING 
methacrylated 
silk fibroin 
10-30% w/v LAP (0.2% w/v) PBS washes digital light 
processing 
NIH/3T3 
fibroblasts 
1-10*106 cells/ml >90% after 
printing 
platform 159
UV CROSS-
LINKING 
PEG-DA 10% w/v Laponite (4%) UV irradiation after 
printing 
extrusion murine 
preosteoblasts 
NIH MC3T3 
E1-4 
0.01*106 cells/ml good (non 
quantitative) 
platform 169
UV CROSS-
LINKING 
PEG-DA 20% w/v Irgacure 2959 
(0.5% w/v) + 
acryloyl-PEG-
RGD (5mM) 
PBS washes stereolithography NIH/3T3 cells 1*106 cells/ml 100% after 
printing 
platform 59
UV CROSS-
LINKING 
PEG-DMA 10% w/v Irgacure 2959 
(0.05% w/v) 
UV irradiation after 
printing 
inkjet human 
articular 
chondrocytes 
8*106 cells/ml 85% after 
printing 
cartilage repair 168
  
 
Table 4 Complex bioinks described in the literature (NA = not assayed, NS = not specified) 
 
TYPE OF 
STRUCTURE 
GELATION 
PROCESS 
NETWORK 
PRECURSOR  
NETWORK 
PRECURSOR 
CONCENTRA
TION 
OTHER 
COMPONENTS 
POST 
PRINTING 
PROCESSING 
PRINTER 
TYPE 
CELL TYPE CELLULAR 
CONCENTRA
TION 
CELLULAR 
VIABILITY 
IN 
VIVO 
ASSAYS 
APPLICATION REF. 
COMPLEX (2 
STEPS CROSS-
LINKING) 
aggregatio
n and 
chemical 
cross-
linking 
thiolated 
gelatin + 
amphiphilic 
peptides 
2.25 wt% 
and 0.75 
wt% 
  soaking in a 
dimaleimide-
PEG (5%) and 
CaCl2 (25 
mM) vat 
extrusion SV40 
immortalized 
mouse 
cholangiocytes 
(SV40SM) 
0.2*106 
cells/ml 
good (non 
quantitative
) 
  bile duct repair 178 
COMPLEX (2 
STEPS CROSS-
LINKING) 
UV cross-
linking and 
aggregatio
n 
Gel-MA + 
gelatin 
5-30% w/v 
and 8-10% 
w/v 
LAP (0.5% w/v) cold receiving 
plate during 
printing and 
UV irradiation 
during and 
after 
extrusion BM-MSCs 5*106 
cells/ml 
90% after 
printing 
  platform 156 
COMPLEX 
(BIOINK WITH  
MICROSPHERES
) 
self-
assembly 
agarose + 
collagen  
1.5% w/v 
and 1.5 
mg/ml 
cell-seeded 
poly(D,L-lactic-co-
glycolic acid) 
(PLGA) porous 
microspheres 
(20% v/v) + NaOH 
(neutralization) 
printing is 
done on iced 
platform then 
incubation at 
37°C 
extrusion 
(multipipet) 
fibroblasts 
L929 and Rat2,  
myoblasts 
C2C12 and 
A10, and the 
epithelial 
TR146 cells 
83*106 
cells/g of 
microsphere
s 
>90% after 
printing 
  platform 100 
COMPLEX 
(BIOINK WITH 
NP) 
UV cross-
linking 
PEG-DMA 20% w/v bioactive glass 
nanoparticles (BG 
45S5, 1-2% w/v) + 
hydroxyapatite 
(1-2% w/v) + 
Irgacure 2959 
(0.05%) 
UV irradiation 
during 
printing 
inkjet 
(modified) 
hBM-MSCs 6*106 
cells/ml 
70% after 
24h 
  bone tissue 
engineering 
101 
COMPLEX 
(BIOINK WITH 
PLASTIC FIBERS) 
ionotropic 
gelation 
sodium 
alginate 
2.5-3.5 wt%  PLA sub-micron 
fibers (2%) 
CaCl2 solution 
(0.2M) 
spraying 
during 
printing 
extrusion human 
articular 
chondrocytes 
3*106 
cells/ml 
>80% after 
printing
cartilage 
regeneration 
148
COMPLEX 
(DECORATED 
BIOINK) 
UV cross-
linking 
PEG-DMA 10% w/v acrylated 
GRGDS (1mM) +  
acrylated MMP-
sensitive peptides 
(1mM) + I-2959 
(0.05% w/v) 
UV irradiation 
after printing 
inkjet hBM-MSCs 6*106 
cells/ml 
90% after 
24h 
platform 57
COMPLEX 
(DECORATED 
BIOINK) 
UV cross-
linking 
PEG-DMA 10% w/v acrylated 
GRGDS (1mM) +  
acrylated MMP-
sensitive peptides 
(1mM) + I-2959 
(0.05% w/v) 
UV irradiation 
after printing 
inkjet hBM-MSCs 6*106 
cells/ml 
NA C57BL/
6 J 
mice 
cartilage repair 58
COMPLEX 
(MULTICOMPO
NENT  BIOINK 
WITH NP) 
UV cross-
linking and 
ionotropic 
gelation 
Gel-MA + 
kappa 
carrageenan 
10% w/v and 
1% w/v 
2D nanosilicates 
(2% w/v) + 
Irgacure 2959 
(0.25% w/v) 
UV irradiation 
after printing 
and 
incubation in 
KCl solution 
extrusion hMSCs 0.333*106 
cells/ml 
90% after 
printing 
platform 102
COMPOSITE (1 
PLASTIC 
SUPPORT + 1 
BIOINK + 1 CELL 
SUSPENSION ) 
ionotropic 
gelation 
and 
aggregatio
n 
1. 
polydopamine-
calcium silicate 
PCL 
2. sodium
alginate + 
gelatin 
3. culture 
medium 
2. 5% and 
30% 
extrusion for 
1. and 2.,
inkjet for 3.
HUVEC in 2. + 
Wharton's jelly 
mesenchymal 
stem cells 
(WJMSC) in 3. 
10*106 
cells/ml in 2., 
NS in 3. 
good (non 
quantitative
) 
bone tissue 
engineering 
114
COMPOSITE (1 
PLASTIC 
SUPPORT + 1 
BIOINK) 
enzymatic 
cross-
linking 
1. PCL and 
pluronic F127
2. fibrinogen + 
collagen (from
rat)
3. thrombin 
1. 10% w/v 
and 5% w/v 
in acetone
2. 10 mg/ml 
and 1.5 
electrospinin
g (1.) and 
inkjet (self 
developed, 
2. and 3.) 
rabbit 
chondrocytes 
3-4*106 
cells/ml in 2.
81% after 1 
week 
nu/nu 
mice 
cartilage repair 94
mg/ml 
3. 20 UI/ml 
COMPOSITE (1 
PLASTIC 
SUPPORT + 1 
BIOINK) 
ionotropic 
gelation 
1. PCL 
2. sodium 
alginate + 
RGD-alginate   
2. 1% total nano 
hydroxyapatite 
pDNA complexes 
incubation in 
CaCl2 solution 
extrusion MSCs 10*106 
cells/ml in 2. 
70% after 1 
day 
  bone tissue 
engineering 
60 
COMPOSITE (1 
PLASTIC 
SUPPORT + 1 
BIOINK) 
ionotropic 
gelation 
1. PCL 
2. sodium 
alginate 
2. 4-6% TGF-β (10 ng/mL)  incubation in 
CaCl2 and 
NaCl solution 
extrusion human primary 
nasal septal 
cartilage 
chondrocyte 
1*106 
cells/ml in 2. 
85% after 
printing 
female 
nude 
mice 
cartilage repair 53 
COMPOSITE (1 
PLASTIC 
SUPPORT + 1 
BIOINK) 
ionotropic 
gelation 
1. pluronic 
2. gellan gum + 
sodium 
alginate 
1. 30% 
2. 3% and 2% 
1. sodium 
chloride (150 
mM) + strontium 
chloride (20 mM) 
2. hydroxyapatite 
or BioCartilage 
product (40% 
w/w polymer) 
incubation in 
SrCl2  solution 
extrusion bovine 
chondrocytes 
6*106 
cells/ml in 2. 
80% after 
printing 
  cartilage repair 
/ construct 
64 
COMPOSITE (1 
PLASTIC 
SUPPORT + 1 
BIOINK) 
ionotropic 
gelation 
1. PCL 
2. sodium 
alginate 
2. 4% w/v   incubation in 
CaCl2  
solution 
extrusion primary rabbit 
chondrocytes 
3*106 
cells/ml in 2. 
good (non 
quantitative
) 
New 
Zealand 
white 
rabbits 
auricular 
cartilage repair 
96 
COMPOSITE (1 
PLASTIC 
SUPPORT + 1 
BIOINK) 
ionotropic 
gelation 
and self-
assembly 
1. PCL 
2. CELLINK® 
(nanofibrilated 
cellulose + 
sodium   
alginate) 
2. 2% w/v 
and 0.5% 
w/v 
  incubation in 
CaCl2 solution 
extrusion (1.) 
and inkjet 
(2.) 
human nasal 
chondrocytes 
20*106 
cells/ml in 2. 
70% after 
printing 
  auricular 
cartilage 
regeneration 
93 
COMPOSITE (1 
PLASTIC 
SUPPORT + 1 
BIOINK) 
self-
assembly 
1. PCL 
2. Matrigel™ 
1. 1.25-1.66 
g/ml in 
chloroform 
2. 9 mg/ml 
1. 13-93B3 borate 
glass (10-50 wt%) 
  extrusion human adipose 
stem cells 
(ASCs) 
10*106 
cells/ml in 2. 
70% after 
24h 
  bone tissue 
engineering 
113 
COMPOSITE (1 
PLASTIC 
SUPPORT + 1 
BIOINK) 
self-
assembly 
1. PCL 
2. dECM (from
adipose,
cartilage
or heart)
2. 3% 2. NaOH
(neutralization)
extrusion 
(self 
developed) 
hASCs, hTMSCs 
or Rat 
myoblast cells 
(L6, ATCC 
CRL-1458) 
1-5*106 
cells/ml in 2.
95% after 
24h 
tissue 
reconstruction 
/ platform 
77
COMPOSITE (1 
PLASTIC 
SUPPORT + 1 
BIOINK) 
self-
assembly 
1. PCL 
2. 
decellularized 
adipose tissue
2. NS 2. NaOH
(neutralization)
extrusion 
(self 
developed) 
 hASCs 2-5*106 
cells/ml in 2.
93% after 
24h 
nude 
mice 
soft tissue 
regeneration 
5
COMPOSITE (1 
PLASTIC 
SUPPORT + 1 
BIOINK) 
UV cross-
linking 
1) PCL 
2) HA-SH + 
poly(allyl 
glycidyl ether-
co-glycidyl) + 
HA 
2. 5 wt%, 5 
wt% and 1 
wt%
2. I-2959 (0.05
wt%) + NaOH
(neutralization)
UV irradiation 
after printing 
extrusion hBM-MSCs 6*106 
cells/ml in 2. 
good (non 
quantitative
) 
cartilage 
engineering 
97
COMPOSITE (1 
PLASTIC 
SUPPORT + 1 
HYDROGEL + 2 
BIOINKS) 
self-
assembly 
1. PCL 
2. 
atelocollagen 
3. 
Cucurbit[6]uril
-hyaluronic 
acid 
4. 1,6-
diaminohexan
e-hyaluronic 
acid 
2. 3% w/v 
3. 5% w/v 
4. 5% w/v 
2. BMP-2 
(5µg/ml) 
3. TGF-β 
(0.1µg/ml) 
extrusion 
(self 
developed) 
human 
turbinate-
derived 
mesenchymal 
stromal cells 
(hTMSCs) 
1*106 
cells/ml in 2. 
and 2*106 
cells/ml in3. 
good (non 
quantitative
) 
rabbits osteochondral 
tissue 
regeneration 
54
COMPOSITE (1 
PLASTIC 
SUPPORT + 1 
SACRIFICIAL INK 
+ 3 BIOINKS) 
UV cross-
linking 
1. 
poly(dimethyl 
siloxane) 
(PDMS) 
2. Pluronic 
F127 (fugitive) 
3. Gel-MA 
4. Gel-MA 
5. Gel-MA 
2. 40 wt% in 
water 
3. 15% w/v 
4. 15% w/v 
5. 15% w/v 
3. Irgacure 2959 
(0.3 wt%) 
4. Irgacure 2959 
(0.3 wt%) 
5. Irgacure 2959 
(0.3 wt%) 
UV irradiation 
after printing 
and 
incubation at 
4°C to 
remove the 
fugitive ink 
extrusion C3H/10T1/2, 
Clone 8 cells 
(ATCC 
CCL-226TM, in 
4.) and GFP-
expressing
human 
neonatal
dermal 
fibroblast cells 
(in 5.) 
2*106 
cells/ml in 4. 
and 5. 
60-70% 
after 
printing
vascularized 
tissue 
engineering 
98
COMPOSITE (1 
PLASTIC 
SUPPORT + 2 
BIOINKS) 
aggregatio
n and 
enzymatic 
cross-
linking 
1. poly 
(e-
caprolactone) 
(PCL) and 
Poly(lactide-
co-
caprolactone) 
(PLCL) 
2. gelatin +  
fibrinogen + 
HA 
3. gelatin +  
fibrinogen + 
HA 
2. 35 mg/ml, 
30 mg/ml 
and 3 mg/ml 
3. 35 mg/ml, 
30 mg/ml 
and 3 mg/ml 
  incubation in 
thrombin 
solution 
extrusion urothelial cells 
(UCs, in 2.) and 
smooth muscle 
cells (SMCs, in 
3.) 
10*106 
cells/ml in 2. 
and 3. 
90% after 1 
day 
  urethra 
production 
82 
COMPOSITE (1 
PLASTIC 
SUPPORT + 2 
BIOINKS) 
ionotropic 
gelation 
1. PCL 
2. sodium 
alginate 
3. sodium 
alginate 
2. 4% w/v 
3. 4% w/v 
  incubation in 
CaCl2 and 
NaCl solution 
extrusion human nasal 
septum 
cartilage 
chondrocytes 
(in 2.) and  
MG63 human 
osteoblast cells 
(in 3.) 
1*106 
cells/ml in 2. 
and 3. 
90-95% 
after 24h 
  osteochondral 
tissue 
regeneration 
95 
COMPOSITE (1 
PLASTIC 
SUPPORT + 3 
BIOINKS) 
self-
assembly 
1. PCL 
2. heart tissue-
derived 
decellularized 
extracellular 
matrix 
(HdECM) 
3. HdECM  
4. HdECM 
2. 20 mg/ml 
3. 20 mg/ml 
4. 20 mg/ml 
2. NaOH 
(neutralization) + 
vitamin B2 (0.02% 
w/v) 
3. NaOH + vitamin 
B2 (0.02% w/v) + 
VEGF (10 µg/ml) 
4. NaOH + vitamin 
B2 (0.02% w/v) + 
VEGF (10 µg/ml) 
UV irradiation 
after printing 
and 
incubation at 
37°C 
extrusion human cardiac 
progenitor cells 
(hCPCs, in 2. 
and 4.) and 
MSCs (in 3. and 
4.) 
5*106 
cells/ml in 2., 
3. and 4. 
> 90% after 
printing 
Balb/c 
nude 
mice 
cardiac repair 52 
HETEROGENEO
US  (1 BIOINK + 
1 HYDROGEL 
WITH CROSS-
LINKER) 
UV cross-
linking 
1. Gel-Ma + 
HA-MA (core)  
2. Gel-Ma + 
HA-MA (shell)  
1. 10 wt% 
and 2 wt% 
2. 10 wt% 
and 2 wt% 
2. VA-086 (0.5 
wt%) 
light 
irradiation 
after printing 
co-axial 
extrusion 
(biopen self 
developed) 
sheep MSC in 
1. 
2.5*106 
cells/ml in 1. 
97% after 
printing 
Sheep cartilage repair 164 
HETEROGENEO
US  (1 BIOINK + 
1 SOLUTION OF 
CROSS-LINKER) 
ionotropic 
gelation 
and UV 
cross-
linking 
1. sodium
alginate + 
GelMA + 
PEGTA (shelf)
2. CaCl2 (core) 
1. 1-3%, 5-
7% and 1-3% 
2. 0.3M 
1. Irgacure 2959 
(0.25% w/v) 
UV irradiation 
after printing 
and EDTA 
solution 
washed to 
remove 
alginate 
coaxial 
extrusion 
HUVECs hMSCs 3*106 
cells/ml in 1. 
80% after 
printing 
vascularized 
tissue 
engineering 
167
HETEROGENEO
US  (1 BIOINK + 
2 SOLUTIONS 
OF CROSS-
LINKER) 
ionotropic 
gelation 
1. sodium
alginate (core)
2. CaCl2 
(inside shelf)
3. CaSo4 
(outside shelf)
1. 3.2% coaxial 
extrusion 
MDA-MB-231 
human 
adenocarcinom
a cells (in 1.) 
and RAW 264.7 
mouse 
macrophage 
cells (in 2.) 
5*106 
cells/ml in 1. 
and 4.5*106 
cells/ml in 2. 
90% after 
24h 
tumour 
microenvironm
ent model 
151
HETEROGENEO
US ( 1 BIOINK + 
1 SOLUTION OF 
CROSS-LINKER) 
self-
assembly 
and 
enzymatic 
cross-
linking 
1. fibrinogen  + 
collagen 
2. thrombin 
1. 25 mg/ml 
and 1.1 
mg/ml 
2. 20 IU/ml 
extrusion 
(self 
developed) 
human 
amniotic fluid-
derived 
stem cells 
(hAFS) or 
hBMSCs 
16.6*106 
cells/ml in 1. 
NA nu/nu 
mice 
wound repair 117
HETEROGENEO
US (1 BIOINK  + 
1 SOLUTION OF 
CROSS-LINKER) 
chemical 
cross-
linking and 
ionotropic 
gelation 
1. sodium
alginate + 
gelatin (core)
2. CaCl2 (shelf)
1. 2% w/v 
and 10% w/v 
2. 0.3 M 
Incubation in 
genipin 
solution 
(0.01% w/v) 
after printing 
coaxial 
extrusion 
hMSCs NS >90% after 
printing
platform 186
HETEROGENEO
US (1 BIOINK + 1 
HYDROGEL) 
aggregatio
n and UV 
cross-
linking 
1. gelatin 
2. PEG-DMA
covering (no 
printing)
1. 3% w/v 
2. 20% w/v 
2. 2-hydroxy- 
2-
methylpropiophe
none (0.1% w/v) 
UV irradiation 
after covering 
droplet 
ejection (self 
developed) 
MCF-7 human 
breast cancer 
cells 
0.5-1*106 
cells/ml in 1. 
100% after 
1h 
cellular 
spheroids 
fabrication 
187
HETEROGENEO
US (1 BIOINK + 1 
HYDROGEL) 
UV cross-
linking and 
ionotropic 
gelation 
1. Gel-MA
(core)
2. sodium
alginate 
(sheath)
1. 1-2% 
2. 1% 
1. CaCl2 (1%) and 
PI (0.2%) 
UV irradiation 
after printing 
co-axial 
extrusion 
HUVECs, MDA-
MB-231, MCF7 
breast cancer 
cells, or 
NIH/3T3 mouse 
fibroblasts 
2*106 
cells/ml in 1. 
>45% after 
printing
Micro-fiber 
construct 
166
HETEROGENEO
US (1 BIOINK + 1 
SOLUTION OF 
CROSS-LINKER) 
ionotropic 
gelation 
and UV 
cross-
linking 
1. sodium 
alginate + Gel-
MA (core) 
2. CaCl2 (shelf) 
1. 2% w/v 
and 7% w/v 
2. 0.3 M 
NS cross-linker UV irradiation 
after printing 
coaxial 
extrusion 
HepG2/C3A 
hepatocytes 
NS >90% after 
printing 
  platform 186 
HETEROGENEO
US (1 BIOINK + 1 
SOLUTION OF 
CROSS-LINKER) 
self-
assembly 
and 
ionotropic 
gelation 
1. sodium 
alginate + 
collagen (core) 
2. CaCl2 (shelf) 
1. 2% w/v 
and 1 mg/ml 
2. 0.3 M 
1. NaOH 
(neutralization) 
  coaxial 
extrusion 
hMSCs, and 
MDA-MB-231 
breast cancer 
cells 
NS >90% after 
printing 
  platform 186 
HETEROGENEO
US (1 
HYDROGEL + 1 
BIOINK) 
self-
assembly 
1. 
polypeptide– 
DNA conjugate 
(poly(l-
glutamic 
acid240-co-g-
propargyl-l-
glutamate20) 
2. double-
stranded DNA 
1. 6 wt% 
2. 2mM 
    inkjet AtT-20 cells (an 
anterior 
pituitary cell 
line 
1.6*106 
cells/ml in 1. 
99% after 
printing 
  platform 115 
HETEROGENEO
US (1 
SACRIFICIAL INK 
+ 2 BIOINKS) 
UV cross-
linking 
1. pluronic 
(sacrificial) 
2. Gel-MA 
3. Gel-MA 
1. 40% w/v 
2. 10% w/v 
3. 10% w/v 
2. Irgacure 2959 
(0.1% w/v) 
3. Irgacure 2959 
(0.1% w/v) 
UV irradiation 
after printing 
extrusion MSC in 2. and 
ACPC in 3. 
20*106 
cells/ml in 2. 
and 3. 
> 75% after 
1 day 
  cartilage repair 10 
HETEROGENEO
US (1 
SACRIFICIAL INK 
WITH CROSS-
LINKER + 1 
BIOINK) 
aggregatio
n and 
enzymatic 
cross-
linking 
1. Pluronic 
F127 
2. gelatin +  
fibrinogen 
1. 38 wt% 
2. 7.5% w/v 
and 10 
mg/ml 
1. thrombin (100 
U/ml) 
2. 
transglutaminase 
(0.1 wt%) 
Stored at 37°c 
for 1h after 
printing then 
cooling at 4°C 
to remove 
the sacrificial 
ink 
extrusion hMSCs NS >60% after 
printing 
  vascularized 
tissue 
engineering 
91 
HETEROGENEO
US (2 BIOINKS) 
UV cross-
linking 
1. Gel-MA  
2. PEG-DA 
1. 5% w/v 
2. 5% w/v 
1/4-4/1 of 1. 
and 2. 
1. TCI 0.5% w/v 
2. TCI 0.5% w/v 
UV irradiation 
after printing 
extrusion Periodontal 
ligament stem 
cells 
(PDLSCs) 
1*106 
cells/ml in 1. 
and 2. 
> 80% after 
printing 
rats in vivo repair 
of 
alveolar bone 
defect 
172 
HETEROGENEO
US AND 
COMPLEX 
(BIOINK WITH 
NANORODS + 
CROSS-LINKER 
SOLUTION) 
ionotropic 
gelation 
and UV 
cross-
linking 
1. sodium
alginate + Gel-
MA + gold
nanorod 
(GNR)-Gel-MA
(core)
2. CaCl2 
solution (shelf)
1. 2% w/v,
7% w/v and 
0-0.5 mg/ml 
1. Irgacure 2959 
(0.25 %) 
UV irradiation 
after printing 
coaxial 
extrusion 
cardiac 
fibroblasts 
5*106 
cells/ml in 1. 
80% after 
printing 
cardiac repair 99
HETEROGENEO
US AND 
COMPLEX 
(BIOINK WITH 
SPHEROIDS + 
CROSS-LINKER 
SOLUTION) 
ionotropic 
gelation 
1. sodium
alginate (core)
2. CaCl2 
solution (shelf)
3. sodium
alginate 
spheroids (2nd 
extruder)
1. 4% w/v 
3. 4% w/v 
coaxial 
extrusion 
(self 
developed) 
Cartilage 
progenitor cells 
(CPCs) 
4*106 
cells/ml in 3. 
60% after 
24h 
tissue 
engineering 
103
HETEROGENEO
US AND 
COMPLEX 
(TUBULAR 
BIOINK 
CONSTRUCT 
WITH 
MICROSPHERES
) 
ionotropic 
gelation 
and self-
assembly 
1. vascular 
dECM + 
sodium
alginate (shelf)
2. pluronic F-
127 (fugitive,
core)
1. 3% and 2 
wt%
2. 40 wt% 
1. Atorvastatin-
loaded PLGA
microspheres (15 
mg/ml) + NaOH
(neutralization)
2. CaCl2 
incubation in 
cell media at 
37°C (removal 
of fugitive ink 
and cross-
linking) 
coaxial 
extrusion 
(self 
developed) 
mouse 
endothelial 
progenitor cells 
10*106 
cells/ml in 1. 
80% after 
printing 
male 
eight-
week-
old 
Balb/c 
nude 
mice 
blood vessel 
construction 
65
HETEROGENEO
US (1 
HYDROGEL + 1 
SOLUTION OF 
CROSS-LINKER 
AND CELLS) 
ionotropic 
gelation 
1. alginate + 
methycellulose
2. trisodium
citrate
1. 3 wt% and 
9 wt%
2. 15 mg/ml 
1. CaCl2 extrusion mouse 
fibroblasts 
L929 
3*106 
cells/ml in 2. 
90% after 
printing 
platform 116
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